<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

A Glimpse into 2023: Regen Med Trends

By Freddy Buntoum on 3/31/23 4:04 PM

PRP and Adipose Through the Looking Glass

The interest and demand for regenerative medicine for various conditions and injuries have increased exponentially over the last decade. From January 1, 1990 to December 31, 2012, google searches for regenerative medicine totaled 21,600,000. With increased publicity about stem cells and advancements in cell and gene therapies, biomaterials and tissue engineering, google searches increased nearly ten-fold to 212,000,000 from 1/1/13 to 2/27/23.

Is regenerative medicine really the way of the future? In this article, SmartTRAK looks at the macroeconomic environment going into 2023, as well as some of the latest trends, with a special focus on two segments: platelet-rich-plasma (PRP) and adipose tissue.
 
Among the may topics covered in detail in this comprehensive article are:
  • PRP Trends and the Impacts to 2023 and Beyond
    • Headwinds in 2023
    • Trends in PRP Clinical Trials
    • Anticipated 2023 US PRP Market Share Standings
  • Adipose Trends and the Impacts to 2023 and Beyond
    • Adipose tissue therapy gaining interest in the field of sports medicine
    • Patient demand for minimally-invasive solutions
    • Adipose-derived cell therapies for OA and Degenerative Disc Disease
So is regenerative medicine the way of the future? Time will tell, however, SmartTRAK feels that demand and interest by multiple stakeholders, along with recent trends, medical and legal advancements and investments is tipping the scale to ...

To download and read the complete "A Glimpse into 2023: Regen Med Trends" article by Freddy Buntoum, SmartTRAK's Senior Analyst, Orthobiologics and Regenerative Medicine, just click the button below.Download the Article

Continue Reading
2 min read

AAOS 2023: Total Joint Viewpoint

By Lisa Mahan on 3/27/23 11:00 AM

AAOS approaches “Next to Normal” as surgeons and industry focus on solutions to meet the needs of patients returning to joint replacement

If an ad agency had branded the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting this year, the tagline would have read “Getting back to normal.” Surgeons toured the exhibit hall throughout the day not just during dedicated hours. The meeting felt as if it had come back to life with industry symposiums and conference presentations often seeing standing-room-only crowds when a few years ago even the exhibit floor felt like a ghost town. And while some of the large orthopedic companies slightly scaled down their booth space, several mid-tier and small market players increased their presence at the meeting in an attempt to pique surgeon interest. So what was the buzz at AAOS 2023 related to hip and knee replacement? In this article, SmartTRAK outlines some of the key takeaways, including: 
  • Procedure Recovery May Signal Return of Deferred Procedures
    • Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...

  • The Move to Outpatient Joint Replacement Continues.
    • Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...

  • Cementless Knee Trend Growing Despite Mixed Results
    • Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...

  • Assistive Technologies Growing and Evolving
    • Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...

To download and read the complete "AAOS 2023: Total Joint Viewpoint" article by SmartTRAK's Lisa Mahan,  VP Product Development & IT, Sr. Analyst TJ&E, just click the button below. Download the AAOS 2023 Article

Continue Reading
2 min read

Compression Therapy Trends to Watch in 2023 and Beyond

By Terry Hayslett on 3/27/23 9:41 AM

SmartTRAK identifies the top trends impacting the Compression Therapy Market in 2023 and beyond, including reimbursement, diagnostic aids, 3M’s spin-off and growth in compression wraps.

Over the next several years, reimbursement changes in the US could impact the US Compression Therapy Market, In 2020, SmartTRAK noted that industry participants should expect increased activity from US advocacy groups seeking to raise awareness of reimbursement restrictions on compression therapy products. 

Among the top trends impacting the Compression Market in 2023 covered in detail in this article are:

  • Trend #1: Expanding Coverage of Lymphedema Compression Therapy
    •  In December 2022, advocacy efforts were rewarded when legislators added coverage of lymphedema compression treatment items to the $1.7 trillion US Consolidated Appropriations Act, 2023 (H.R. 2617). Among many other provisions, the Bill provides Medicare coverage of ...

  • Trend #2: Innovation in Diagnostic Aids
    • The lack of objective measurement of lymphatic function hinders the effective diagnosis and treatment of lymphedema. Lymphedema is typically diagnosed based on a patient’s underlying risk factors and physical symptoms. In some cases, imaging technology such as ...

  • Trend #3: 3M’s Health Care Spin-off Shifting Market Dynamics
    • SmartTRAK noted in a recent article that 3M’s spin-off of its Health Care business could lead to a more focused and stronger leader in advanced wound care. SmartTRAK does not categorize compression therapy as advanced wound care, however, compression is ...

  • Trend #4: Growth in Compression Wraps
    • SmartTRAK continues to track the growth of compression wraps via publicly available data sources. Compression wraps are growing strong in the UK, driven by the belief that the products improve patient compliance, reduce the need for professional intervention and are more cost-effective. The same drivers support growth in the US; however, the US Medicare system only provides reimbursement of compression wraps for qualifying wounds ...

To download and read the complete "Compression Therapy Trends to Watch in 2023 and Beyond" article by Terry Hayslett, SmartTRAK's Senior Analyst, Advanced Wound Care. just click the button below. Download the Article

Continue Reading
2 min read

Strong Revenue Growth: Q422 Total Joints Market Highlights

By Lisa Mahan on 3/24/23 9:42 AM

Procedure recovery above Q4 seasonality, new products and assistive tech push strong revenue growth

  For Q422, the US Hip Replacement Market grew +8.4% according to SmartTRAK Financial Dashboard . Newer products, implant pull-through from assistive technologies and procedure recovery continued to positively impact growth. Nearly all companies in our reporting universe cited procedure recovery as a growth driver.
 
The US Knee Replacement Market grew +9.3% in Q422, driven in part by knee procedure recovery. Recovery appeared to be above that of the typical year-end seasonality of patients trying to fit in surgery before insurance deductibles reset. SmartTRAK has heard rumblings that the growth seen in Q4 may be a sign that ...
 

To read more about the strong revenue growth in the Total Joints Market, including Procedure Recovery, New Products and Assistive Technologies Driving Growth in the Hip Market and Cementless Knees and Enabling Tech Expanding the Knee Market, just click the link below.

 
* This link and the complete unedited article can only be viewed by SmartTRAK  subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please  click  the button below.Learn More about Subscribing to SmartTRAK
Continue Reading
2 min read

The 2023 Market Outlook for Advanced Dressings in Europe

By Lennart Stadler on 3/21/23 9:36 AM

From new products to macroeconomic headwinds and some regulatory turbulence, SmartTRAK looks at trends to watch for in Europe in 2023.

The European Advanced Dressing Market is forecast to grow at a 2021-2026E CAGR of +3.2%, according to SmartTRAK estimates. The market grew +2.9% in Q322 and +4.8% YTD, impacted by strong growth in H122 (+5.8%).

Advanced Dressings is a market that is spread relatively evenly across geographies, with Europe holding a 43.9% share of the worldwide (WW) market, with the US Advanced Dressings Market at a 28.5% share and ROW 27.6%.

In this 2023 Market Outlook article, SmartTRAK highlights market and regulatory factors that will affect growth in the European Advanced Dressing Market in 2023, including:
  • New Product Launches Coming Back
  • Transitioning to the European Medical Device Regulations
  • Continued Macroeconomic Headwinds in Specific Countries
  • The Reimbursement-Related Threat of Silver Dressings in Germany
Continue Reading
2 min read

Navigating Choppy Waters: Q422 Neuromodulation Market Recap

By Anne Staylor on 3/20/23 10:06 AM

While the macro environment is improving, some neuromodulation companies and segments navigated choppy waters in Q422

While the macro environment continued to improve in Q422, the waters remain choppy for some neuromodulation companies and segments.  Competitors are making gains on new and differentiated product offerings, strengthening demand and expanding indications. These gains are offset by the residual effects of the pandemic, reimbursement challenges, stubborn inflationary pressures and currency exchange headwinds." For FY22, the spinal cord stimulation (SCS) segment showed signs of recovery by year-end while deep brain stimulation (DBS) slowed on replacement headwinds for some companies.
 
Among the many topics covered in detail in our comprehensive Q422 Neuromodulation Market Recap* article:
  • Complete Q422 Neuromodulation Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Spinal Cord Stimulation Sees Growth Exiting 2022
  • Macro Environment Improving
  • Innovation, Expanding Indications Driving Growth
  • Potential Payer Headwinds
  • DBS Slows on Replacement Headwinds, Share Shifts
  • Q422 Clinical/Regulatory Highlights
Continue Reading
2 min read

US Surgical Matrices Rebound: Q422 Market Recap

By Doug Devens on 3/17/23 9:30 AM

Breast Matrices rebound and grow modestly as AbbVie’s competitors take over market share. Biosynthetic and hybrid xenograft hernia matrices continue to drive growth in Hernia Matrices.

The US Surgical Matrices Market resumed its pre-pandemic trends, gaining +3.2% YoY according to SmartTRAK Financial Dashboard. AbbVie* and Becton Dickinson* (BD) remained in first and second positions, respectively, in the Q422 Surgical Matrices market. AbbVie held on to its leadership despite  a -4.4% YoY decline, while BD gained +6.1% YoY.

Among the many topics covered in detail in our comprehensive Q422 US Surgical Matrices Market Recap* are:

Continue Reading
2 min read

Saluda Medical: Changing the Game in Spinal Cord Stimulation

By Anne Staylor on 3/13/23 9:53 AM

Saluda Medical President and CEO Jim Schuermann discusses the Company, the Evoke System and changing the game in SCS in an interview with SmartTRAK

With the US launch of the Evoke System, Saluda Medical is changing the game in spinal cord stimulation (SCS). At the North American Neuromodulation Society (NANS) Annual meeting in Las Vegas in January, researchers presented impressive 36-month data from the Company’s Evoke Study and the Company was showcasing its Evoke System for the first time on the NANS exhibit hall floor. As the first commercially available closed-loop SCS system using evoked compound action potentials (ECAPs), Evoke is unlike anything on the market. The technology automatically adjusts stimulation to maintain precise and consistent neural activation to the spinal cord for the treatment of intractable low back and leg pain. The Company received FDA PMA for Evoke in February 2022 and announced a limited US commercial release in December 2022, calling it the first and only ‘SmartSCS” in the US.

Saluda Medical President and CEO Jim Schuermann discusses bringing Evoke System to market, the Company’s US launch and commercialization plans, the newest generation of Evoke, his vision for the future and Evoke’s potential impact on the market in an interview with SmartTRAK. Click the button below to download and read a complete transcript of the interview. Download the Interview Transcript

Continue Reading
2 min read

2023 US Hernia Matrices Outlook: Recent Trends and Potential Impact

By Doug Devens on 3/10/23 9:41 AM

SmartTRAK reviews recent trends in hernia matrices and their potential impact on the US Hernia Matrices Market, which is projected to reach $1.06B in 2023 according to SmartTRAK.

Incisional hernia procedures reached a peak in the mid-2000s, with a gradual decline as surgeons performed fewer abdominal procedures and researchers investigated new techniques for closure. While improved stitching for closure has had mixed results, surgeons are trying other new approaches to reduce incisional hernias such as MSI’s DuraMesh* and Deep Blue Medical’s T-line mesh* which are being used prophylactically.

In this Market Outlook article, we cover in detail:

  • Synthetic Matrices Poised for Slow Down
  • Alternatives to Synthetic Matrices Gaining Favor
    • Xenograft Matrices
    • Resorbable Meshes
    • Reinforced Xenograft Matrices
  • Expert Analysis and Conclusions
Continue Reading
2 min read

What Lies Ahead For Orthobiologics in 2023 and Beyond

By Kim French on 3/6/23 9:30 AM

Market Dynamics, Industry Moves and Technology Advancements 

In 2022, the Orthobiologics Market encountered both ups and downs. Though companies are still reporting year-end results, SmartTRAK feels the Orthobiologics Market finished on a high note. The 2022 challenges, such as staffing shortages at healthcare facilities, supply chain constraints and inflation, may cause headwind in 2023, stifling some growth.

Nevertheless, SmartTRAK anticipates the potential downsides will be offset by elective procedures returning to pre-COVID levels, along with progressive, transitional initiatives by select market players that have the potential to reshape certain orthobiologics segment landscapes.

Among the many topics covered in this Market Outlook article are:

  • Reshaping the Competitive Landscape
  • Shifts in the US Bone Replacement Market
  • Advancements in Osteobiologics
  • Shifts in the US Sports Medicine Market
Continue Reading
3 min read

Advanced Oxygen Therapy, Inc: The Value of Durable Healing

By Kris Flinn on 3/3/23 3:41 PM

SmartTRAK interviews Advanced Oxygen Therapy Inc CEO and President Dr. Mike Griffiths to discuss how durable healing can improve health equality

Continue Reading
2 min read

Oxygen & Energy Devices in Wound Care: Outlook for 2023

By Kris Flinn on 3/2/23 9:21 AM

With many of the “hard yards” already run, SmartTRAK believes that 2023 could be a promising year for the Oxygen and Energy segments of the Advanced Wound Care Market.

SmartTRAK estimates the 2021 WW Oxygen and Energy Market at just over $50.0MM. While this is not an insignificant amount, it trails far behind other Advanced Wound Care markets such as Negative Pressure Wound Therapy (NPWT) and Biologics. Last year, however, showed signs that clinicians are starting to realize the potential of these technologies. Here SmartTRAK looks at how some of the existing players in the markets for oxygen and energy therapies may show increased success in 2023 and why some of the leading wound care companies may soon be taking their first steps into these markets.

Among the many topics covered in this article are:

Topics: Wound Care
Continue Reading
9 min read

What's New in Orthopedics Research & Development

By Thomas Wallick on 2/27/23 11:28 AM

In recent years, there have been significant advances in orthopedic treatments, surgical techniques and rehabilitation methods that have transformed the way we approach musculoskeletal disorders.SmartTRAK continues to report daily, in real-time. on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.

SmartTRAK features curated content by our team of industry experts, bringing the most relevant information and insight directly to you in real-time. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos and interviews and Be The Expert.

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

  • NuVasive*

    NUVA spoke about its upcoming product launches, including an expandable Lateral called MOD-EX XLIF and extended blade-fixation options for Modulus ALIF, and predicted that both will support the continued interest in NUVA. NUVA Q422 Earnings Transcripton Seeking Alpha

  • GMED mgmt stated the ortho robot will launch w/ a knee application first w/ other applications to follow, noting it is unlikely that gap-filling joint implant systems would be launched prior to the knee application for robotics. GMED Q422 Earnings Transcript on Seeking Alpha

  • CurvaFix announced a it will launch the 7.5 mm CurvaFix IM Implant, which received FDA clearance in Oct 2022, at this year’s AAOS annual meeting in Las Vegas. BusinessWire

Patents:

  • SeaSpine*

    7D Surgical was granted US Patent “Systems And Methods For Intraoperative Spinal Level Verification” disclosing the use of segmented surface data from volumetic pt image data compared w/ intra-op surface data to verify spine levels w/o x-rays. 11564752

  • Method for Treating Joint Pain  

    US Patent "Method for treating joint pain" was granted relating to treating joint pain by inserting a bone dowel and BMA into the subchondral of a bone and introducing BMA into the intra-articular space of the joint being treated. 11583402

Continue Reading
2 min read

Total Joints Trends Heading Into 2023

By Lisa Mahan on 2/27/23 9:00 AM

SmartTRAK examines conditions lowering the flame for Total Joints

Procedural growth strengthened in 2022 giving rise to the hope that a backlog of patients created by the COVID pandemic would return to surgery, stoking the fires of Total Joint Market recovery. However, external market forces appear to be setting the market to simmer in 2023 while other forces influence the recipe for success for market players.
 
An analyst from JP Morgan has  drawn  parallels between the current behavior of the US stock and bond markets and the conditions leading up to the 1969 recession, according to a recent  Forbes  article. Interest rate hikes and high inflation have increased the likelihood that the US economy will face a recession in 2023. But what does that mean for the Total Joints Market?
 

Among the many topics covered in detail in this comprehensive article are:

Continue Reading
2 min read

2023 Extremities Trends to Watch

By Lisa Mahan on 2/21/23 12:17 PM

SmartTRAK highlights trends affecting the US Extremities Market in 2023

The Extremities Market continues to be a hotbed of activity heading into 2023. SmartTRAK highlights trends that will continue to affect the US Market for Extremities in 2023, including CMS reimbursement obstacles, new product introductions and potential mergers and acquisitions.
 

Among the many topics covered in detail in this comprehensive article are:

  • SmartTRAK's Expert Market Analysis and Insights
  • Outpatient Shoulder Replacement Growing Despite Lack of CMS Reimbursement
  • New Shoulders May Heat Up Competition
  • New Ankle Products and Technologies May Boost Growth
  • New Products, DTC and Potential M&As Heat Up Extremities Fixation
  • M&As on the Horizon

To download and read the complete "2023 Extremities Trends to Watch" article, just click the button below.Download the Extremities Trends Article

The countdown to AAOS 2023 on March 7-11 in Las Vegas has begun and the SmartTRAK team will be attending...see you there!

Continue Reading
2 min read

SmartTRAK is Seeking a Medtech Marketing Coordinator

By Gabriele Nichols on 2/17/23 10:26 AM

Do you love working with a dynamic, experienced team of marketing and sales professionals? Are you looking for a position that leverages your industry knowledge and marketing skills in new ways? Do you thrive in a start-up like atmosphere with plans for exponential growth? If you are a current or former marketing professional who has worked within the Life Sciences (especially medical device) industry, we would love to talk with you.

SmartTRAK is the leading strategic advisory and healthcare analytics provider in the orthopedic, wound care, neuro therapies and regenerative medicine markets. Our customers — which include most of the largest global orthopedic and wound care companies -- rely on our “insights-as-a-service” platform for their market research and business intelligence. We are expanding our team by seeking an experienced marketing associate to drive a variety of key marketing initiatives. This person will be responsible for coordinating with the Marketing, Sales and Customer Success teams to increase awareness of SmartTRAK, including through social media, email, website, paid advertising and events.

We’re looking for a conscientious, team-player, who can thrive in a fast-paced entrepreneurial/small business environment. Our candidate is comfortable working remotely and is both collaborative and self-driven. They must have excellent written and verbal communication skills and be able to utilize a variety of marketing tools. Click the button below to learn more and apply.

Learn More and Apply

Topics: Medtech
Continue Reading
2 min read

Focus on Skin Substitutes and Debridement: 2023 Boswick Symposium

By Gary Delhougne on 2/14/23 9:33 AM

New products from Kerecis, Vericel, Epien, PixaMed and the role of debridement take center stage.

The 45 th  Annual JAB Maui Burn & Wound Symposium met on January 21-26 with a significant focus on the use of skin substitutes and proper wound bed debridement. Though some clinical presentations focused on chronic, surgical and other trauma wounds, burns dominated the agenda. Compared to diabetic foot ulcers (DFUs), pressure injuries and other chronic wounds, there are fewer burns, but their unique treatment requirements and impact on patients increase the importance of targeted therapies. In the US,   SmartTRAK estimates there were approximately 496,530 burns requiring treatment in 2021 with 40,870 burns requiring hospitalization. SmartTRAK estimates the burn market will reach 513,550 cases requiring treatment by 2026 with hospitalization for 42,270 cases (+0.7% 5-year CAGR).

Treating burns with skin substitutes dominated the clinical presentations and discussions on the exhibit hall floor. A close second discussion point was the role of proper wound bed preparation or debridement. This article highlights new products from Kerecis*,Vericel*, Epien Medical, PixaMedand the role of debridement in wound healing.  

Among the many topics covered in detail in the complete article, which is available as a download, are:

Continue Reading
3 min read

Spotlight on Medtronic Neuromodulation: NANS 2023

By Anne Staylor on 2/10/23 11:40 AM

Medtronic executives Nnamdi Njoku and Charlie Covert discuss Medtronic’s latest initiatives in Neuromodulation in an interview with SmartTRAK at NANS 2023

Nnamdi Njoku, Medtronic’s Senior Vice President and President Neuromodulation, and Charlie Covert, Vice President and General Manager of Pain Therapies, discuss what’s new for Medtronic Neuromodulation, expected market growth in 2023 and strategies for driving growth in spinal cord stimulation (SCS) and deep brain stimulation (DBS) in an interview with SmartTRAK at the North American Neuromodulation Society (NANS) 26th Annual Meeting held January 12-15, 2023 in Las Vegas, Nevada.

To find out more about the Company’s latest innovations, expanding indications and what’s next for Medtronic Neuromodulation, click on the following video recorded live at NANS 2023. (27:57 minutes.) Specific interview topics by time code are outlined below. A link to download a complete transcript of the interview is also provided below.

Continue Reading
3 min read

Meet The Expert: Neil Beals - Senior Analyst, Spine & Spine Biologics

By Thomas Wallick on 2/6/23 3:05 PM

We are pleased to announce that Neil Beals has joined the team at SmartTRAK as our new Senior Analyst, Spine and Spine Biologics. Neil has 30+ years’ experience working in leadership roles in R&D, technology management, marketing and market development, with extensive responsibilities in identifying, developing, and commercializing new technologies. His experience includes executive management positions at Smith & Nephew, Medtronic Spine & Biologics, Ellipse Technologies and Nuvasive Specialized Orthopedics along with consulting with innovative medical device start-ups.

Meet Neil Beals:

What is your role with SmartTRAK? I am a Senior Analyst for Spine and Spine Biologics.

What do you like about SmartTRAK? I like the fact that SmartTRAK is the leader in market intelligence for the highly competitive life sciences industry.  I also like that SmartTRAK provides a unique resource for a wide range of stakeholders.  The SmartTRAK team has tremendous industry-related experience and works collaboratively in pursuing opportunities, addressing challenges and responding to its subscribers.

Continue Reading
2 min read

Current Trends in Sports Medicine

By Andy Knapik on 2/2/23 10:20 AM

Dr. Scott Sigman, founder and chief medical officer of OrthoLazer Orthopedic Laser Centers and host of the Ortho Show podcast, discusses current trends in arthroscopic sports medicine and orthopedic care in an in-depth interview with SmartTRAK.

In an interview with SmartTRAK, Scott Sigman, MD discusses many trends in arthroscopic technologies and soft tissue fixation including advancements in anterior cruciate ligament (ACL) repair with the BEAR Implant, graft selection in ACL reconstruction, the Stryker InSpace Balloon for massive rotator cuff tears, advancements in Latarjet, needle arthroscopy and more. Dr. Sigman is the chief medical officer and founder of OrthoLazer Orthopedic Laser Centers and the host of the Ortho Show podcast. 

To find out more about Dr. Sigman’s insights on sports medicine and arthroscopy, click on the following video to watch Andy Knapik, SmartTRAK's Sr. Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies, interview Dr. Sigman (49:55 min). A complete transcript of the interview is available here. For more details, interview topics by timecode are provided below.

Continue Reading
5 min read

SmartTRAK's Top 10 Blog Posts of 2022

By Thomas Wallick on 2/2/23 9:00 AM

As the COVID-19 epidemic waned and companies got back to business as usual, SmartTRAK continued to keep you informed of everything that transpired in the MedTech industry in 2022. Here are SmartTRAK's Top 10 blog posts of the past year that garnered the most attention from you and your colleagues, plus 4 bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!

As the leading provider of real-time market data and analysis for the orthopedic, wound, regenerative medicine and neuro therapies markets, SmartTRAK is uniquely suited to make you the expert on all the latest developments. Our knowledgeable analysts covered a lot of ground, everything from breaking medical device event coverage to interviews with some of the industry's top thought leaders.

Medtronic: The Future of Neuromodulation in 2022 and Beyond
by Anne Staylor

Dave Anderson, Medtronic’s President Neuromodulation, and Charlie Covert, Vice President and General Manager of Pain Therapies, discuss the Company, the pandemic and the future of neuromodulation in a wide-ranging interview with SmartTRAK.

Continue Reading
2 min read

Emerging Technologies in Neurointervention

By Anne Staylor on 1/31/23 9:30 AM

SmartTRAK identifies emerging technologies at the most recent SNIS and ESMINT meetings that have the potential to disrupt the market for neurointervention.

In the market for neurovascular devices, companies continue to innovate and are focusing research and development efforts into novel technologies that could lead to improved outcomes and help fuel growth in the market for ischemic and hemorrhagic stroke devices. At two recent neurointerventional meetings, the Society for NeuroInterventional Surgery (SNIS) 19th Annual meeting and the 14th European Society for Minimally Invasive Neurological Therapy (ESMINT) Congress 2022, SmartTRAK identified emerging technologies that could potentially disrupt the neurovascular market over the next two to five years. This includes enabling technologies for neurointerventional procedures, novel approaches to aspiration for the treatment of acute ischemic stroke (AIS) and innovation in intrasaccular flow disruption devices.

Among the many interesting topics covered in this informative article are:

  • Enabling Technologies for Neurointervention
    • Corindus' CorPath GRX System
    • Robotic-assisted Neuroendovascular Navigation
  • Update on Aspiration
    • Cyclical Aspiration
    • Modulated Aspiration
  • Advances in Intrasaccular Flow Disruption Devices
Continue Reading
3 min read

Personalized Arthroplasty: The Future of Total Joint Surgery?

By Nick Fitzpatrick on 1/26/23 10:22 AM

SmartTRAK interviews Dr. Pascal-André Vendittoli to learn more about the Personalized Arthroplasty Society and this year’s annual meeting.

Dr. Vendittoli explains the difference between mechanical and kinematic alignment, what he looks for in total joint computer-assisted surgery systems and why he thinks personalized arthroplasty is the future of joint surgery. To find out more, listen to the SmartTRAK interview with Dr. Vendittoli in the video below (14:56 min). A link to download the transcript of the complete interview is also provided below.
Continue Reading
3 min read

The Future of PEKK in Orthopedics: An Interview w/ Oxford Performance Materials' Scott Felice

By Nick Fitzpatrick on 1/23/23 10:18 AM

SmartTRAK interviews Oxford Performance Materials CEO Scott DeFelice to learn more about the company’s PEKK-based materials solutions in orthopedics.

In an interview with   SmartTRAK, Oxford Performance Materials’ (OPM) CEO Scott DeFelice explains the history of his company, the difference between PEKK, PEEK and titanium-based implants and the Company’s future plans in the orthopedic space.

To find out more, including OPM’s plan to expand into the custom trauma market and its planned release of an all-polymer total knee, just click on the following video to listen to the full interview. (29:13 min).  A link to download a transcript of the complete interview is also provided below.

Continue Reading
2 min read

Headwinds Persist: Q322 Arthroscopic Technologies Market Recap

By Andy Knapik on 1/20/23 11:01 AM

Headwinds persist for the Arthroscopic Technologies Market in Q322

With most of the major headwinds caused by COVID-19 in the rear-view mirror, the Arthroscopic Technologies (AT) Market showed growth in the third quarter with WW Arthroscopic Technologies revenues up +4.2% over Q321. The quarter saw a continued rise in procedural volumes globally that resulted in growth for the AT disposables market which trends with case volumes. On the capital side of the AT Market, capital spending and demand remained strong for items such as arthroscopic camera systems with new equipment purchases as well as an increasing need for replacement capital driving demand.

Among the many topics covered in detail in our comprehensive Q322 Arthroscopic Technologies Market Recap* are:

Continue Reading
2 min read

The Past, Present and Future of 3M Health Care

By Susan Paquette on 1/17/23 9:18 AM

With the recent announcement that 3M is spinning off its Health Care division, SmartTRAK looks back at the evolution of 3M Health Care, its businesses today, the entry into Advanced Wound Care (AWC) and potential new opportunities for the new Health Care business.

3M, a large, diversified company with annual sales of $35.4B in 2021 announced earlier this year plans to spin-off its Health Care business into a new public company. Today, 3M markets thousands of products through four business groups: Safety and Industrial, Transportation and Electronics, Health Care and Consumer. Post-spin-off, 3M will continue as a leading global material science innovator, while the new stand-alone business will seek to become a global diversified healthcare company focused on wound care, healthcare IT, oral care and biopharma filtration.

Download "The Past, Present and Future of 3M Health Care" Article
Among the many topics covered in this fascinating article are:

Continue Reading
2 min read

A Shifting Procedural Landscape: Q322 Spine Market Recap

By Courtney Sheedy on 1/12/23 9:52 AM

SmartTRAK reports that Q322 Spine Market performance drove a lack of consensus on operational performance metrics, while a shifting procedural landscape offered new product opportunities for small and mid-tier players, driving competitive pressure.

Among the many topics covered in detail in our comprehensive Q322 Spine Market Recap* are:

Continue Reading
2 min read

Neuromodulation Trends: SmartTRAK at NANS 2023

By Thomas Wallick on 1/10/23 9:00 AM

SmartTRAK takes a look back at Neuromodulation Trends in 2022 and looks forward to reporting on emerging trends at NANS 2023

Anne Staylor, SmartTRAK's Executive Editor VP & GM, Neuro Therapies, will again be attending and reporting on the North American Neuromodulation Society Annual Meeting (NANS), this year being held in Las Vegas, January 12-15th. If you would like to meet with Anne while at NANS, just click here.

Last year, Anne published a prescient article from the NANS 25th Annual Meeting titled "Neuromodulation Trends in 2022 and Beyond" in which she identified key trends from the meeting in Orlando and provided an outlook of what’s on the horizon for neuromodulation. This included trends in research and technology that will help shape the markets for spinal cord stimulation (SCS), deep brain stimulation (DBS) and peripheral nerve stimulation (PNS), advances in closed-loop therapies, improving care through digital solutions and driving growth through expanding indications.

To download and read the complete "Neuromodulation Trends in 2022 and Beyond" article, just click here.  

Continue Reading
2 min read

Continuing the Ascent: Q322 US Surgical Matrices Market Recap

By Doug Devens on 1/9/23 10:47 AM

Biosynthetic hernia matrices continue their ascent and Xenograft hernia matrices grow, thanks to TELA Bio.

As elective surgical procedures settle into pre-pandemic levels, the US Surgical Matrices Market resumed trends that had begun prior to Q322, gaining +2.4% YoY according to SmartTRAK Financial Dashboard. AbbVie* and Becton Dickinson* (BD) have been trading share positions in the last few quarters and now once again AbbVie has first place in the Q322 Surgical Matrices market despite of a -5.4% YoY decline, with BD In second place.

Among the many topics covered in detail in our comprehensive Q322 US Surgical Matrices Market Recap* are:

Continue Reading
2 min read

New Products and Easier Comps Drive US Growth: Q322 Trauma Market Recap

By Natasha Weeks on 1/3/23 9:30 AM

Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of new products.

While OUS results declined in Q322 due to foreign currency headwinds and China’s value-based pricing, the US drove the overall market through product penetration and easier comps due to the Q321 COVID waves that impacted procedural volumes last year. Companies posted healthy US growth, attributing new products for driving growth, with plans for additional launches in Q4 and 2023.

Among the many topics covered in detail in our comprehensive Q322 Trauma Market Recap* are:

Continue Reading
2 min read

Wrestling with Issues and Headwinds: Q322 Neuromodulation Market Recap

By Anne Staylor on 12/29/22 9:30 AM

Growth in the SCS and DBS segments remained soft in Q322 as companies continue to wrestle with macro-environmental issues and currency headwinds

Neuromodulation continued to face a challenging macro environment in Q322 related to stubborn inflationary pressures, currency exchange headwinds and unpredictable surges in COVID affecting supply chains and healthcare staffing in certain geographies. However, some competitors reported seeing steady signs of improvement in the quarter and are looking to expanded indications and new technologies to help drive growth.

Among the many topics covered in detail in our comprehensive Q322 Neuromodulation Market Recap* are:

Continue Reading
2 min read

Trends in ADM Use from ASPS 2022

By Doug Devens on 12/20/22 9:30 AM

Surgeons are concerned about the cost of breast matrices in an increasingly restrictive environment, but alternatives may be on the horizon according to key discussions at the 2022 Plastic Surgery: The Meeting.

Breast matrices are used to cover breast implants in breast reconstruction and cosmetic breast surgeries. The matrices have become in effect standard of care in these surgeries, though they do not have FDA-approved indications for breast reconstruction or cosmetic breast surgeries. Moreover, the FDA has in recent years, issued warning letters and communications related to breast matrices. In 2015, the FDA issued warning letters reminding several companies that they did not ...

To read the complete "Trends in ADM Use from ASPS 2022" article by Doug Devens, SmartTRAK's Product Director/Sr. Analyst - Wound, in which  he shares observations from the ASPS sessions and the potential implications for the Breast Matrices Market, just click the following link.

Download the complete "Trends in ADM" Article

Continue Reading
2 min read

A Tidal Wave of Competitors: Q322 CAS Spine Market Recap

By Shelly Caruso on 12/19/22 6:41 PM

Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under development by a host of companies in the market for spine enabling tech.

Q322 was nothing short of a tidal wave of competitive entrants to the US Spine Robotic Surgery space. Medtronic* (MDT) and  Globus* remain top players as OUS companies like France’s  eCential Robotics* and Taiwan’s  Point Robotics MedTech* set their sights on the US market. The Q322 WW CAS Spine Market was up, according to  SmartTRAK Financial Dashboard. MDT remained the market leader with 49.0% share, followed by Globus and other enabling tech competitors like Brainlab* and Stryker* (SYK).

Among the many topics covered in detail in our comprehensive Q322 CAS Spine Market Recap* are:

Continue Reading
2 min read

Raging Like a Beast: Q322 US Joint Fluid Replacement Market Recap

By Freddy Buntoum on 12/16/22 9:30 AM

CMS Reimbursement changes raging like a beast to belabor several HA market players

For Q322, the true impact of CMS reimbursement changes was blatantly apparent, with the US Joint Fluid Replacement Market showing an overall lackluster revenue performance, with a YoY decline of -4.7% vs Q321, according to SmartTRAK Financial Dashboard. As if the new CMS regulations were not enough, the swing toward negative growth was also driven by hyaluronic (HA) companies battling for product placement, preferred formulary status with private payers, overall inflation, and still to a certain degree, supply chain-related issues stemming from COVID-19 and subsequent waves of the different variants. Aggregate revenue being in the red for the third quarter of 2022 was mainly the result of negative YoY growth across three of the four HA segments. Still, with an anticipated hard push to more positive year-end results, the US Joint Fluid Replacement Market is trending toward achieving on or ever so slightly above  SmartTRAK’s US Joint Fluid Replacement Market Overview revenue projections

Among the many topics covered in detail in our comprehensive Q322 US Joint Fluid Replacement Market Recap* are:

Continue Reading
3 min read

Big Data is Dead. This is the Time for SmartTRAK Insights.

By Sharon O'Reilly on 12/12/22 1:53 PM


As the CEO of SmartTRAK, I understand Medtech executives often drown in data and need quick, easy access to market insights from a trusted source. According to a Forbes article Big Data is Dead. Long Live Smart Data, the “more Data-is-Better” era is over, and it is time for Smart Data. And that means a SmartTRAK subscription is more important than ever.

SmartTRAK is the Medtech’s industry first and only “Insights-as-a-Service(IaaS) solution, curating data from hundreds of data sources, including public and commercial databases as well as extensive attendance and coverage of industry conferences. Our team of industry experts and data scientists do the work for our customers, providing actionable intelligence and insights from data that is already cleaned, verified and featurized. Our proprietary data curation methodology powers the SmartTRAK platform, which can be accessed on demand 24x7 across the enterprise.

Continue Reading
3 min read

Bolt Navigation: Simplifying Spinal Navigation-An Interview with CEO Patrick West

By Shelly Caruso on 12/12/22 10:00 AM

SmartTRAK interviews Bolt Navigation CEO Patrick West to learn more about the Company and its potentially disruptive solution for streamlined spinal navigation.

One of the most exciting enabling technologies on display at the recent North American Spine Society (NASS) 2022 annual meeting in Chicago was the Bolt Navigation System, a novel, FDA-pending technology developed by Bolt Navigation to simplify spinal navigation. Designed by a practicing neurosurgeon, Bolt utilizes a software application to leverage the positional guidance inherent in an iPhone for intraoperative spine screw planning and placement guidance. The system works without a reference frame and can be used with a patient's diagnostic MRI or CT and a single C-arm shot once the patient is positioned. It is implant agnostic and can be attached to almost any instrument.

To find out more about Bolt Navigation and this potentially disruptive solution for streamlined spinal navigation, listen to SmartTRAK’s interview with CEO Patrick West in the following video (30:47 min). A link to a transcript of the complete interview is also provided below.

Continue Reading
2 min read

Elective Procedure Volumes Improving: Q322 Total Joints Market Trends

By Lisa Mahan on 12/8/22 9:30 AM

Even stronger foreign exchange headwinds inhibit revenue growth from steadily improving elective procedural trends 

Procedural volumes appear to be steadily improving overall as the COVID pandemic comes close to the end of its third year. Despite the return of procedures, foreign currency headwinds in Q322 strengthened, negatively impacting reported revenue growth for most companies in markets outside the US. Global companies with a strong international presence were most adversely affected.

Among the many topics covered in detail in our comprehensive Q322 Total Joints Market Recap* are:

  • Complete Q322 Total Joints Market Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Improving Procedural Volumes Leaning into Strengthening Foreign Exchange Headwinds
  • Hips: Muscle-Sparing Solutions and New Products Driving Growth
  • Knees: Assistive Tech Driving Implant Pull-Through
  • Q322 Regulatory Highlights
Continue Reading
3 min read

SmartTRAK is Seeking a Senior Analyst: Spine and OrthoBiologics/Regen

By Sharon O'Reilly on 12/6/22 4:08 PM

Do you love keeping up with the latest trends in the Spine and OrthoBiologics/Regen medicine markets? Are you a closet investigative reporter who loves researching and analyzing what’s going on in the market? Are you looking for a position that leverages your industry knowledge, expertise and connections in new ways? If you are a current or former marketing, market research or business development professional who has worked with one of the major orthopedic/spine companies and looking for a career change, we would love to talk with you.

We are looking to strengthen our SmartTRAK Spine and OrthoBiologics/Regen modules with the addition of a qualified person with industry specific experience. All SmartTRAK analysts are former marketing, business development or R&D professionals with one of the major orthopedic/spine suppliers and, in fact, most have come to us via recommendations from our subscribers, as well as those in the industry. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add we can offer SmartTRAK subscribers.

We are looking for someone with Spine and OrthoBiologics/Regen industry experience who is interested in working full-time. Click the button below to learn more and apply. Learn More and Apply

Continue Reading
2 min read

The Future of Skin Substitute Reimbursement: SAWC Fall 2022

By Gary Delhougne on 12/6/22 9:30 AM

The potential of US reimbursement changes to Skin Substitutes weighed heavily on companies at SAWC Fall, yet subsequently, CMS decided to delay finalizing its proposed changes.

The Symposium on Advanced Wound Care (SAWC) Fall 2022 gathered for another year in Las Vegas. The exhibit hall was filled with most wound care manufacturers and though booth hours were short, the clinical attendees made the best of their time searching out the latest in wound care technologies.

In this articleSmartTRAK discusses:

  • Alternative Product Developments to the Skin Substitute Market 
  • Potential Impact of Proposed Reimbursement Changes
  • The Top Four Companies by Revenue 
  • CMS' Proposed Terminology Change from “Skin Substitute”
  • Packaging Skin Substitutes as “Incident to” Supplies
Continue Reading
10 min read

What's New in Trauma and Extremities?

By Natasha Weeks on 12/5/22 10:12 AM

In the market for Trauma & Extremities, companies continue to innovate with new product introductions as well as a value-based care approach that promotes supporting clinical evidence for new and existing products showing their benefits to the patient and the hospital. Manufacturers are investing in solutions beyond implants to differentiate themselves and gain share in the Trauma & Extremities markets. SmartTRAK has observed a variety of strategies and solutions in the fast-paced hallux valgus segment as well as investment in deformity correction and periprosthetic solutions. The following is a sample of SmartTRAK's recent Trauma & Extremities news and developments from around the world, compiled, curated and posted in real-time by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more. Our users think it's the perfect way to start their day.

New Products:

  • CAPTIVATE Cannulated Screw System* - Globus*

    Globus announced the launch of the CAPTIVATE Headed Cannulated Screw System in diameters 2.5/3.0 mm, 3.5/4.0 mm, 4.5/5.5 mm. SmartTRAK reviewed the products at OTA with Globus as the Company fills out its Trauma & Extremities portfolio. LinkedIn

  • Stryker launched the Gamma4 System, the next-gen IM nail system from the IM Nail market leader (45.6% US share in 2021) according to SmartTRAK’s Financial Dashboard. The new system features a precision pin, redefined nail design and integrated instrument.

Continue Reading
2 min read

Economics and the Shift to ASCs: SmartTRAK at AAHKS 2022

By Lisa Mahan on 11/29/22 9:30 AM

Highlighting the economic conversation at AAHKS 2022 changing the landscape of joint replacement

At the American Association of Hip and Knee Surgeons (AAHKS) 2022 Annual Meeting in Dallas, SmartTRAK identified economics as a leading conversation theme under the guise of other topics. AAHKS 2022 itself was not immune to rising economic pressures as many clinicians were rumored to have backed out of attending the meeting and several exhibiting companies scaled down their participation as well. Surgeons not only attended sessions to enhance their clinical knowledge, but they also discussed facing the challenges of reduced reimbursement. In the exhibit hall, Companies featured products and technologies seemingly geared towards the shift of hip and knee replacement procedures to the more cost-conscious ambulatory surgery center (ASC) setting.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

  • Economic Pressures
  • Reimbursement Challenges 
  • The Decline of CMS Physician Primary Hip Replacement Reimbursement
  • Manufacturers Targeting ASCs, including:
    • Smith& Nephew
    • ConFormMIS
    • Exactech
    • Maxx Medical
    • DePuy Synthes
Continue Reading
2 min read

Key Trends in Enabling Technology for Spine: NASS 2022

By Elise Wolf on 11/28/22 10:18 AM

For the first time in recent years, robotics was not a main headline in the academic program at NASS 2022, but SmartTRAK notes that the exhibit floor was buzzing with exciting new developments in enabling technology.

Although there were limited program sessions focused solely on enabling technology at NASS 2022, the floor was abuzz with digital solutions, including recently launched and upcoming products. Based on conversations with NASS exhibitors, SmartTRAK identified key trends in the market for spine enabling technology including new spine robotic systems, augmented reality (AR) platforms and compact navigation solutions, as well as advances in surgical planning and unveiling of digital ecosystems. These innovations will help drive double-digit growth in the US market for Spine Enabling Technologies.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

  • Beyond Robotics: Leveraging Data and Ecosystems
  • Battle Bots: New Spine Robots on Display
  • Augmented Reality Positioned to Target ASCs
  • Small-Footprint Platforms and Disposable Spinal Navigation
  • Problem-Solving Differentiated Technology
Continue Reading
2 min read

Currency Movements Overshadow Underlying Business Growth in 2022

By Lennart Stadler on 11/22/22 9:30 AM

SmartTRAK looks at recent currency fluctuations and the impact on company performance and underlying growth in 2022

Ask CEOs what their top priority is and a vast majority will answer: “Grow top-line revenue.” Not only that, but they also want to grow faster than their peers, taking market shares. But how do you determine if one company is performing better than the other when company reporting includes varying currency rates and geographies? In this article, SmartTRAK discusses different types of financial reporting, compares the recent impact of currency movement on companies competing in the Advanced Wound Care (AWC) Market and reviews the best metric for assessing company performance and underlying growth across companies.

Among the many topics covered in detail in this fascinating article, which can be downloaded in its entirety here, are:

  • Financial Reporting: Comparing Apples to Apples
  • Currency Impact on Reported Growth
  • Q222 Growth Details for Key Wound Companies
  • Currency Impact per Quarter in % by Key Wound Companies
  • Currency Impact Over Time
  • Organic Growth Over Time
Continue Reading
1 min read

Trends and Advancements in Foot & Ankle: AOFAS 2022

By Natasha Weeks on 11/17/22 9:38 AM

SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFAS 2022

SmartTRAK identified several key themes and takeaways from the American Orthopaedic Foot & Ankle Society (AOFAS) 2022 meeting held recently in Quebec City, Canada. Manufacturers showcased product introductions with a continued focus on hallux valgus solutions and are investing in solutions beyond implants to differentiate themselves and gain share in the US Foot & Ankle Market.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

  • Small, Niche Players Attempt to Gain Share
    • Globus Fills Out Trauma and Extremities Product Portfolios
    • Enovis Showcases New Products and Gains Traction in F&A Space
  • Direct-To-Consumer Marketing Drives Growth in Hallux Valgus Market
    • Treace Medical Outpaces Others
    • Medartis Showcases New Products
    • JNJ/DePuy/Synthes' Acquisition
    • Paragon28 Focuses on the MIS Segment

To download the complete "AOFAS 2022: Trends and Advancements in Foot & Ankle" article by SmartTRAK's Natasha Weeks, Sr. Analyst, Trauma & Extremities, just click the button below.Download the AOFAS 2022 Article

Continue Reading
2 min read

Trends and Advancements in Trauma: OTA 2022

By Natasha Weeks on 11/14/22 11:34 AM

SmartTRAK highlights the latest trends and innovations at OTA 2022, with a focus on deformity correction and limb lengthening.

Our expert analysts focus in on the latest advancements, key trends and takeaways from the Orthopedic Trauma Association (OTA) meeting in Tampa, Florida held October 12–15, 2022. Major trauma manufacturers showcased innovation through new product introductions.

Stepping Outside of Internal Fixation

In the market for ring fixation devices, companies have been innovating beyond static frames and are developing dynamic, computer-assisted hexapod frames to treat bone fractures and deformity corrections. One of the challenges with hexapod frames is that they require manual strut adjustments, a process that is prone to patient and clinician error and can require up to 20 manual adjustments per day—a definite burden on the patient and caregiver ...

Download the complete "Key Trends & Advancements in Trauma" Article

Continue Reading
2 min read

Orthobio & Regen Medicine Highlights from the ICRS 16th World Congress - Berlin 2022

By Freddy Buntoum on 11/11/22 9:42 AM

Highlighting the latest research, technology developments and innovations taking place in orthobiologics and regenerative medicine at ICRS 2022

This year the International Cartilage Regenerative & Joint Preservation Society (ICRS) hosted its 16th World Congress in Berlin, Germany, and SmartTRAK covered it. This was the Society’s first in-person meeting since October 2019, and without a doubt, a very exciting moment for ICRS, its members and all who attended the event. For four days, industry stakeholders from around the world converged in Berlin to learn and hear about the latest research, technology developments and innovations taking place in orthobiologics and regenerative medicine. In this article, SmartTRAK gives a recap of some of the main topics presented during the meeting.

Among the many fascinating topics covered in the complete article, which can be downloaded here, are:

  • The Role of Extracellular Vesicles 
  • Use of Minced Cartilage
  • Autologous, Matrix-induced Chondrogenesis 
  • Feasibility of Gene Therapy
  • Other Therapies of Tomorrow
Continue Reading
3 min read

SmartTRAK Advances Medtech Market Insights Platform - New Wound Care and Orthopedic/Spine Injectables Modules Added

By Gabriele Nichols on 11/8/22 3:30 PM

SmartTRAK, the leading global Medtech business and market insights platform in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, announces the expansion of its solutions portfolio focused on new market coverage for Wound Debridement and Injectables for spinal disc degeneration and osteoarthritis (OA) of the knee.

SmartTRAK is an Insights-as-a-Service platform that equips customers with real-time, accurate market, company and product insights from hundreds of carefully curated data sources. The solution includes rich content provided through a SaaS platform and includes daily updates, tools and dashboards along with direct access to market analysts and expert advisory services.

Wound Debridement, a newly covered segment offered on the SmartTRAK platform, is foundational to wound healing and the success of every advanced wound care product. According to Wound Care market expert and General Manager Gary Delhougne, “our new module will cover the full scope of the debridement market opportunity and will be beneficial to companies directly participating or contemplating entering into the debridement space.” The Wound Debridement module is now widely available to customers.

Continue Reading
3 min read

Digital Solutions in the Wound Care Arena: An Interview w/ Sofia Heddson Fransén

By Anikó Szekér on 11/8/22 9:00 AM

Sofia Heddson Fransén, Essity’s Global Solution Owner, Intelligent Medical Solutions discusses the Company’s recent digital app launch as well as current and future trends in the digital field in an interview with SmartTRAK at SAWC Fall 2022.

Digital healthcare plays an increasingly important role in healthcare today. In the face of global concerns related to epidemics and pandemics, high costs and the effects of staff shortages, digital health-related technology continues to grow in importance and evolve. A broad scope of stakeholders are involved in the digital health field, including patients, practitioners, application developers and medical device manufacturers and distributors.

To find out more about Essity and the Company’s initiatives around digital solutions in wound care, click the video below to listen to the interview in which Sofia Heddson Fransén, Essity’s Global Solution Owner, Intelligent Medical Solutions, discusses the Company’s recent digital app launch and what the current and future trends in the digital field (05.33 min) are. A link to download the complete interview transcript is also provided below.

Continue Reading
2 min read

Meet Sara Cooley - Relationship Manager, Customer Success

By Thomas Wallick on 11/4/22 1:44 PM

We are pleased to announce that Sara Cooley has joined the team at SmartTRAK as Relationship Manager, Customer Success. Sara has 5+ years of experience in Account Management and Sales in the medical device industry with a concentration in Orthopedics, Neurosurgery, and ENT. Her prior roles were with Kairos Surgical, an Arthrex Distributor, and American Surgical Company.

Meet Sara Cooley:

What is your role with SmartTRAK? Relationship Manager, Customer Success.

What do you like about SmartTRAK? I love that Smarttrak is helping to create an innovative industry by giving companies the information they need to make smart, strategic decisions based on industry trends.

Continue Reading
2 min read

NASS 2022: Emerging Markets and Trends in Spine

By Courtney Sheedy on 11/3/22 9:30 AM

SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and drive advancement in the spine market, including the shift of fusion procedures to the ASC setting, a potential tipping point for the adoption of endoscopic spine care, and emerging innovations within the interbody space.

At the North American Spine Society (NASS) 2022 Annual Meeting in Chicago, SmartTRAK witnessed a revival in energy that has been absent in recent years due to COVID-19, healthcare disruption and industry M&A integration. Exhibitors had the opportunity to teach attendees about new technology in a multitude of ways – a new live surgical theater was proudly projected throughout the exhibit hall and most companies were equally inviting to conversations about macro technology developments. Though SmartTRAK has seen so much innovation in spine over the recent several years, which of these advancements will truly lead to improved patient care? SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and drive growth in the spine market over the coming two-to-five years. These include the shift of procedures from the hospital to outpatient and ambulatory surgery center (ASC) settings, increased adoption and adaptation within surgical approaches and the introduction of custom interbody implants, and many others.

Among the many topics covered in detail in this article are:

Continue Reading
2 min read

OrthoBio-Focused Themes Emerging from NASS 2022

By James Petricek on 10/28/22 1:12 PM

Observations and analysis from the 37th Annual North American Spine Society (NASS) Meeting held October 12-14 in Chicago, IL. 

SmartTRAK highlights the top news and themes at NASS 2022 affecting the markets for OrthoBio and Regenerative Medicine, including the Orthofix/SeaSpine  merger, the ongoing controversy surrounding BMP-2, new product launches, company growth strategies and the latest research and innovation in intradiscal therapies.

Among the many topics covered in detail in this article are:

  • A Spine Merger That Will Significantly Impact The Orthobiologics Landscape
  • BMP-2 Safety Profile Remains an Open Issue
  • Incremental Product Improvement Across OrthoBio Categories
  • Spine Strategic Portfolio Strategies
  • Intradiscal Treatments Take Center Stage

Undoubtedly, the proposed business combination of Orthofix and SeaSpine announced immediately prior to NASS was the most impactful news emanating from the meeting. On a proforma basis, the combined company is expected to generate approximately ...

To download and read the complete "OrthoBio-Focused Themes Emerging from NASS 2022" article by James Petricek,  SmartTRAK's GM, OrthoBio and Regenerative Medicine, just click the button below.Download the Article

Continue Reading
5 min read

SmartTRAK Announces New Chief Growth Officer Linda Bernier

By Thomas Wallick on 10/26/22 10:15 AM

SmartTRAK is pleased to announce that Linda Bernier has been named new Chief Growth Officer (CGO). Linda will oversee Sales, Customer Success and Marketing. She will be involved with projects ranging from customer retention and satisfaction, licensing new tools and data sources, new products and strategy, marketing and new messaging, among others. She comes with a depth of experience in the healthcare and SaaS world, having held CEO and Chief Marketing Officer positions during her career

"Linda has great leadership and interpersonal skills (positivity, woo and communication are among her top strengths), and she likes to put ideas into action and get things done (achiever and strategic also in her top 5). Above all, she brings the experience, knowledge and confidence we have needed to successfully make the pivot to becoming a SaaS company with our new SmartTRAK Enterprise offering." SmartTRAK CEO Sharon O'Reilly

Meet Linda Bernier, SmartTRAK's new Chief Growth Officer:

What is your role with SmartTRAK? As Chief Growth Officer, my main objectives are to execute our founder and CEO Sharon O’Reilly’s vision for SmartTRAK and to achieve the company’s full potential as the leading market insights solution for the MedTech industry. In my role, I’ll be working with the sales, marketing and customer success teams to execute key initiatives to profitably grow the company. These initiatives include increasing client engagement, continuing our stellar > 95% retention rate through voice of client, acquiring new clients, elevating the SmartTRAK brand and expanding SmartTRAK’s portfolio of products and services, including the potential entry into new markets.
 
What do you like about SmartTRAK? When I listen to customers, they consistently say SmartTRAK is their trusted source for

Continue Reading
5 min read

Could Reverse Hips Change the Total Hip Game?

By Lisa Mahan on 10/24/22 10:02 AM

Hip Innovation Technology is betting on its Reverse HRS Hip to change the practice of total hip replacement

Most recent innovations in hip replacement have focused on the use of new materials, new surgical approaches and new assistive technologies. However, one company, Hip Innovation Technology* (HIT), is betting on its investment to change the practice of total hip replacement with an innovative design resulting in the world’s first reverse hip system. The Company is getting even closer to realizing a payoff on this bet by receiving US FDA Investigational Device Exemption (IDE) approval in January 2022 to initiate a pivotal multi-center clinical trial to evaluate the HIT Reverse Hip Replacement System (Reverse HRS)*. Most likely, HIT will be ready to submit for FDA approval of the device following the primary completion of the IDE trial slated for July 2026.

Who is Hip Innovation Technology?

Located in Boca Raton, Florida, Hip Innovation Technology is a privately held company formed in 2011 with the vision of developing and marketing orthopedic device solutions. The Company got its start through a seed round of funding with an initial raise of $225K. George Diamantoni, chief executive officer, is also the founder and CEO of Joint Innovation Technology, HIT’s parent company. He has over 25 years of experience in the healthcare industry including positions at The Upjohn Company, Pharmacia Corporation, Pfize, and Schering Plough. Zafer Termanini, MD, FACS, the inventor of the Interlocking Reverse Hip, serves as the president and chief medical officer of HIT. Termanini, an orthopedic surgeon with over 30 years of experience, is also a Diplomate of the American College of Disability Analysts and the American College of Forensic Examiners, with specialties in Orthopedic and Joint Reconstruction, Sports Medicine and Biomechanical Analysis.

What is a Reverse Hip Replacement?

Continue Reading
10 min read

What's New in the Total Joints Market?

By Lisa Mahan on 10/21/22 11:11 AM

In the market for Total Joint Replacement, companies continue to innovate with assistive technologies and new implants and instruments to advance clinical outcomes and increase efficiency of care. From new hip products optimized for the direct anterior approach to cementless knee solutions, companies are focusing on technologies that provide optimal outcomes whether surgeries are performed in a hospital, hospital outpatient or ASC setting. The following is a sample of SmartTRAK's recent Total Joints news and developments from around the world, compiled, curated and posted in real time by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more. Our users think it's the perfect way to start their day.

New Products:
  • JNJ/DePuy Synthes*

    JNJ/DePuy Synthes did not discuss its new EMPHASYS hip implants during its Q322 earnings call. However, SmartTRAK would not be surprised to see the Company introduce the system at AAHKS 2022 with the EMPHASYS Cup* recently receiving 510(k) clearance to round out the platform.

  • Exactech announced the successful first surgeries and limited launch of the Novel Total Hip Arthroplasty System with the Spartan Stem* and Logical Cup* with full commercial US launch planned for H123. Exactech is a distributor of the implants supplied by Signature Orthopaedics*.

Continue Reading
1 min read

Trends & Advancements in Sports Medicine & Arthroscopy: SmartTRAK at OSET 2022

By Andy Knapik on 10/17/22 9:30 AM

SmartTRAK highlights new products and company strategies for penetrating the ASC market at OSET 2022

The Orthopedic Summit Meeting (OSET) found itself in a new location and time this year as meeting organizers moved a long-time December meeting in Vegas to fall in Boston at the Encore Hotel and Casino. The overall mood of the meeting was positive and seemingly well attended, however, it seems that the change of venue and time of year may have negatively affected overall attendance versus past years. 

All the regular players from a company perspective were in attendance, some showcasing new products and others looking to demonstrate procedural prowess as everyone looks to strengthen their foothold on the hot ambulatory surgery center (ASC) market.   

New Product Introductions: Biologics-Backed Fixation Takes Center Stage

Continue Reading
2 min read

Orthofix & SeaSpine Merge: Create a Leading Global Spine and Orthopedics Co.

By Courtney Sheedy on 10/14/22 9:49 AM

OFIX and SPNE announced a definitive agreement to combine in an all-stock merger of equals. Both companies believe there are meaninful cross-selling revenue synergies, as well as at least $40MM in YoY cost savings to capture over the 3 years following the transaction. The companies have expressed revenue goals of ~$1.0B concluding year 3 post-merger.

Looking forward, the new organization will be a spine and orthopedics company with complementary portfolios in biologics, spinal hardware, bone growth therapies, orthopedic solutions and enabling surgical technologies. SmartTRAK notes that once merged, the new company will be strategically positioned in high-growth emerging technology, including cervical disc replacement with M6-C, enabling technology with 7D’s FLASH Navigation System and OrthoNext preop planning, and with focused development in spine and limb within pediatrics. Additionally, the new company will have a highly competitive offering in the spinal interbody space with its WaveForm 3D and NanoMetalene technologies. Together, the combined company’s biologics portfolio will also represent one of the broadest offerings available in spine and orthopedics.

Find out how to receive SmartTRAK Daily Updates in your morning email

SmartTRAK believes the complimentary product portfolios provide a comprehensive offering and

Continue Reading
3 min read

Astura Medical Reveals New Products Launching at NASS 2022: An Interview with CEO Joel Gambrell

By Courtney Sheedy on 10/12/22 10:02 AM

 In an interview with SmartTRAK, Joel Gambrell, Co-founder and CEO for Astura Medical, shares the series of new products launching at NASS and, specifically, reveals what makes Astura’s new Integrated Expandable ALIF System, El Capitan, truly differentiated.

Since the Company was founded in 2014, Astura Medical has achieved fast growth, established a reputation for elegance and quality in its product offering and taken a different methodology to both product development and business operations. In an interview with SmartTRAK, Joel Gambrell, Co-founder and CEO, provides insight on how Astura’s R&D process is unique, unveils why Astura’s approach to custom implants offers the most real-time precision and reveals the distinctions that make the new Integrated Expandable ALIF System, El Capitan, truly differentiated. In addition to El Capitan, Astura Medical will be launching several other new technologies at the North American Spine Society’s (NASS) annual 2022 meeting in Chicago. 

SmartTRAK's spine experts will be roaming the floor at NASS 2022, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest news and innovations in the Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.  If you would like to book a meeting with us at NASS, just click here.

Continue reading to find out how to download a complete transcript of SmartTRAK's interview with CEO Joel Gambrell.

Continue Reading
9 min read

What's New In the Spine Market: SmartTRAK at NASS 2022

By Courtney Sheedy on 10/7/22 2:46 PM

With the North American Spine Society (NASS) 2022 annual meeting next week in Chicago, anticipation builds to see if some of the top players' product launches are unveiled at the event, including potential new offerings from Medtronic and NuVasive. Meanwhile, SmartTRAK expects to see bright spots from some of the pure-play companies like Centinel, Alphatec and Astura Medical. The event will surely be a pick-me-up from sluggish market performance plagued by budget constraints and supply chain issues. 

Our spine experts will be roaming the floor, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest in the spine market and discuss how SmartTRAK can help you Be the Expert in your market. To make sure you’re up to speed before the meeting, here is a sample of recent spine news collected and curated by the expert analysts at SmartTRAK. If you would like to book a meeting with us at NASS, please click the button below. Schedule a Meeting

New Products:

  • prodisc C* - Centinel Spine*

    Centinel Spine announced expansion of the prodisc cTDR portfolio. Currently, Centinel has 510(k) clearance for 1-level indications for prodisc C Vivo, prodisc C SK and prodisc C Nova giving them the broadest global offering in cTDR.

Continue Reading
9 min read

What's New in the Computer Assisted Spine Market: SmartTRAK at NASS 2022

By Elise Wolf on 10/7/22 2:35 PM

Spine enabling tech companies continue to report positive momentum moving into H222 despite limited hospital budgets, chip shortages and continued staffing issues. The North American Spine Society (NASS) 2022 annual meeting next week is sure to provide a preview of what is coming next for both spine robotics from players like Medtronic and Globus, as well as surgical guidance solution providers such as NuVasive and SeaSpine. We are also looking forward to new enabling tech solutions to be launched at the meeting.

Our spine experts will be roaming the floor, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest in the CAS Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.

To make sure you’re up to speed before the meeting, here is a sample of recent CAS Spine news collected and curated by the expert analysts at SmartTRAK. If you would like to book a meeting with us at NASS, please click the button below. Schedule a MeetingNew Products:

  • Stryker*

    SYK announced the launch of its Q Guidance System for spine applications, which includes surgical planning and intra-op guidance for spine procedures in patients age 13 and older.

Continue Reading
9 min read

What's New in Wound Care in China

By Lennart Stadler on 10/7/22 11:13 AM

As one of the fastest growing markets globally, China is a key market for companies competing in the Advanced Dressings Market. China is the second largest Advanced Dressings Market in the world and is projected to grow in the high single digits over the next five years according to SmartTRAK estimates. Not surprisingly, most of the global leaders in the Advanced Dressings Market have a presence in China, either via distributors or a direct sales force or through manufacturing sites, including Coloplast, WEGO, Mölnlycke and Smith+Nephew, among others.

To find out more about these companies and what’s new in the China Advanced Dressings Market, SmartTRAK highlights market updates covering the top news on new products, clinical studies, deals/financing, market trends, clinical/regulatory and company revenues. Following are some recent updates that were gathered and curated by our expert analysts and sent out to subscribers in SmartTRAK's Daily Updates. To discover how to learn more about the China Advanced Dressings Market, click here.

New Products:

  • China NMPA Approvals in August

    In August 2022, NMPA approved 210 medical devices. Among them, 161 were domestic Class III devices, 25 imported Class III and 22 imported Class II devices. One NPWT kit from Nantong Changyu Medical Technology Co., Ltd. was the only wound care product.

  • ForYou Medical announced that they received a China NMPA approval for LUOFUCON Silicone Foam to be sold in China. Class III, National Machinery Note 20223140748. The dressing is manufactured by ForYou Medical, available in several anatomical shapes.

Topics: Wound Care
Continue Reading
3 min read

The Future of Endoscopic Spine Surgery: An Interview with Choll Kim, MD, PhD

By Courtney Sheedy on 10/6/22 9:30 AM

Dr. Kim outlines his extensive experience in adopting endoscopic spine surgery and reflects on barriers to widespread adoption, including the learning curve and reimbursement challenges

Endoscopic and arthroscopic technology has been around for a number of years, aiding surgeons’ visualization to treat patients in much less invasive ways than were previously possible. Prior to the introduction and adoption of these types of technology, surgeons were faced with invasive, more traumatic procedures and sometimes limitations on visualization based on anatomy. Less invasive approaches have allowed patients to benefit from less risk, shorter hospital stays and, in many cases, quicker healing.

Endoscopic approaches to spine surgery have been taking place for 10+ years, but the market hasn’t experienced transformative growth. All the patient benefits align with relative adoption trends, so why haven’t we seen endoscopic spine surgery grow at a similar rate? What does the future look like in this segment? SmartTRAKsat down with minimally invasive spine surgery pioneer Choll Kim, MD, PhD to explore his thoughts on focusing his minimally invasive surgical practice around specific offering of endoscopic spinal techniques, what the pros and cons have been within the adoption curve of the technology and where he thinks the market is headed.

SmartTRAK's spine experts will be roaming the floor at NASS 2022, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest news and innovations in the Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.  If you would like to book a meeting with us at NASS, please click here.

Continue reading to find out how to download a complete transcript of SmartTRAK's interview with Dr. Kim.

Continue Reading
4 min read

New Approaches in Foundational Wound Care: Wild on Wounds 2022

By Gary Delhougne on 10/4/22 9:42 AM

Wild on Wounds (WOW) focused clinicians back to the essential skills and products of wound care

Nurses, doctors and industry descended on a beachfront resort in Hollywood, FL, from September 7 through 10, for educational sessions and hands-on learning in foundational wound care at Wild on Wounds 2022 (WoW). WoW, as its fun name suggests, is designed for those clinicians focused on, and desiring foundational knowledge in skin and wound care. In reflecting on this focus,SmartTRAKnoted conference buzz and product innovation at this year’s WoW centered on the use of advanced wound dressings and negative pressure wound therapy (NPWT) over other conferences that include more biologics.

SmartTRAK will also be attending the upcoming SAWC Fall conference, covering everything new, exciting and important from the event. Our experts are ready to answer your questions, share insights on the latest in the wound market and discuss how we can help you Be the Expert in your market! If you'd like to meet with SmartTRAK at SAWC, please reach out.

Kicking off WoW, clinician presenters highlighted many “buzz” worthy products and what differentiates them across numerousSmartTRAK-covered product categories. For instance:

Topics: Wound Care
Continue Reading
2 min read

Swings in Robotic Performance: Q222 CAS Spine Market Recap

By Elise Wolf on 9/28/22 9:30 AM

A market fraught with challenging hospital budgets, chip shortages and continued staffing issues results in apparent swings in robotic performance. On the other hand, enabling tech platforms companies continue to report positive momentum moving into H222.

The Q222 WW CAS Spine Market was down YoY according to SmartTRAK Financial Dashboard. Medtronic* (MDT) remained the market leader, followed by Globus* (GMED) and other enabling tech competitors including Stryker* (SYK) and Brainlab*. For detailed Q222 revenues and shares by company in the US, EU and ROW, see SmartTRAK CAS Spine Financial Dashboard*.

Among the many topics covered in detail in our comprehensive Q222 Computer Assisted Surgery Spine Market Recap* are:

  • Complete Q222 CAS Spine Market Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News including Revenues, Data, Charts and Shares
  • Variable Robotics Performance in a Difficult Climate
Continue Reading
4 min read

EPUAP 2022– Diagnostics to Enhance Prevention

By Kris Flinn on 9/27/22 9:30 AM

SmartTRAK highlights novel diagnostic devices for pressure ulcer (PU) prevention and interviews PU Sensor’s CEO Johannes Walfidsson at EPUAP 2022

According to SmartTRAK incidence and prevalence data*, there were over 10 million pressure ulcers in Europe in 2021, with four million being stage III to IV. This means that pressure ulcers account for around two-thirds of the total number of chronic wounds on the continent and almost half of the hard-to-heal wounds. Given these eye-opening statistics, it would be understandable to expect that the first European Pressure Ulcer Advisory Panel (EPUAP) Meeting in three years would indicate growing engagement in this area, both clinically and commercially. Unfortunately, on the evidence of the event in Prague, this wasn’t the case, with delegate numbers declining from previous years and a sparse exhibition hall missing many of the prominent wound care players. This begs the question; why isn’t there a greater focus on pressure ulcers and prevention? (Click to listen to SmartTRAK's interview with PU Sensor's CEO Johannes Walfidsson, "Advancing Risk Assessment for Pressure Ulcers." You can also download a complete transcript of the interview here)

Topics: Wound Care
Continue Reading
5 min read

SmartTRAK Announces New VP of Sales, Joe Mish

By Thomas Wallick on 9/26/22 10:13 AM

SmartTRAK is pleased to announce that Joe Mish has been named new VP of Sales and will lead our commercial team. Before joining SmartTRAK two years ago, originally as Director of Sales, Joe had 10+ years experience in medical device sales, with a concentration on Joint Replacement and Spine & Robotic Technologies. Joe sold and implemented analytic software to manage value-based care and bundled payment, working with Stryker, LDR/ZimmerBiomet and Stryker Performance Solutions.

"I couldn't be more pleased to have a true professional with data analytics/IT/SaaS plus medical device background like Joe in this position. I think you will agree that he is the right person to bring SmartTRAK to the next level." - SmartTRAK CEO Sharon O'Reilly

Meet Joe Mish, SmartTRAK's new VP of Sales: 

What do you like about SmartTRAK? I truly love the value we bring to our customers. With the world being so volatile and medical device markets still being disrupted in so many ways, we offer clients a predictable way to stay ahead of their competition. This is extremely rare. There is no better feeling than standing behind a company and product that you really believe in…we are focused and committed to building long term relationships and strategic partnerships with our customers, and it shows.

Continue Reading
2 min read

Continued Growth: Q222 Advanced Wound Care Market Recap

By Gary Delhougne on 9/22/22 9:30 AM

WW Advanced Wound Care continues to grow in the mid-single-digits as company revenues reflect normalcy in wound care with a likely increase in wound severity.

For Q222, SmartTRAK Financial Dashboard reports the WW Advanced Wound Care (AWC) market grew +6.4%. WW Advanced Dressings and WW Wound Biologics were also up, while NPWT-heavy External Devices revenue increased marginally.

Among the many topics covered in detail in our comprehensive Q222 Advanced Wound Care Market Recap* are:

  • Complete Q222 AWC Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News including Revenues, Data, Charts and Shares
  • Growth Analysis – Currency Having a Significant Impact in Q2
Continue Reading
2 min read

Pain Intervention: A Market of Moving Targets

By Shelly Caruso on 9/20/22 9:30 AM

SmartTRAK highlights key movements in the quickly changing landscape of interventional pain management and identifies practice trends surrounding SCS, PNS, minimally invasive spine and SI Joint Fusion from the recent ASPN and INS meetings.

Strong demand for alternatives to narcotic pain management combined with an aging population and growing incidence of chronic pain continue to drive demand for interventional pain techniques. The approach to the treatment of chronic intractable pain is evolving, with a shift toward data-focused treatment optimization, growing use of digital monitoring and holistic evaluation of patient outcomes. Furthermore, increasing overlap among various devices and therapies as well as unclear boundaries between interventional pain, orthopedic and spine practices is spurring physicians to adopt collaborative approaches to patient care.

Among the many timely topics covered in this comprehensive Market Outlook article "Pain Intervention: A Market of Moving Targets", which can be downloaded in its entirety here, are:

Continue Reading
2 min read

New Products Will Drive Growth: Q222 Trauma Market Recap

By Natasha Weeks on 9/19/22 9:24 AM

Quarterly growth stalled due to weather, supply chain and staffing, but the promise of new product introductions in H2 will return healthy growth to the Trauma Market.

The Q222 Trauma Market was impacted by several conditions that contributed to decelerating growth, such as a reduced demand for trauma-related devices, supply chain challenges and facility staffing hurdles. The WW Trauma Market growth slowed sequentially in Q2, down compared to Q122’s growth. The US Trauma Market fared a bit better than WW results, but also experienced a sequential slump compared to Q122. For the first half of 2022, the US Trauma Market was up +3.5% YTD growth compared to H121.

Among the many topics covered in detail in our comprehensive Q222 Trauma Market Recap* are:

  • Complete Q222 Trauma Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News including Revenues, Data, Charts and Shares
  • Mergers & Acquisitions
  • Q222 Trauma Regulatory Highlights
Topics: Trauma
Continue Reading
2 min read

Future Growth? Q222 Extremities Market Recap

By Lisa Mahan on 9/15/22 9:30 AM

A variety of conditions decelerated Extremities Market growth, but new product introductions should accelerate future growth 

Companies across the Extremities space reported a variety of conditions decelerating growth in Q222, including supply chain challenges, elective procedure cancellations due to COVID, facility staffing issues and reduced demand for trauma-related devices. WW Extremities Market growth slowed sequentially in Q222 compared to Q122. The US Extremities Market also saw slowing sequential growth. Moving forward, SmartTRAK  expects Extremities market growth to accelerate as headwinds lessen and new product introductions boost revenue.
 

Among the many topics covered in detail in our comprehensive Q222 Extremities Market Recap* are:

Continue Reading
3 min read

Onlay vs Inlay Glenoids: An Interview with John Uribe, MD

By Lisa Mahan on 9/13/22 9:30 AM

John Uribe, MD, discusses inset glenoid technology and the future of shoulder replacement

John Uribe, MD, discusses his most recent research and experience with inset glenoids and how inset glenoids could influence the practice of shoulder replacement surgery. Dr. Uribe is a dual board-certified orthopedic surgeon with Baptist Health Group South Florida specializing in sports medicine, arthroscopic surgery and minimally invasive surgical procedures for degenerative knee, shoulder and elbow conditions. He is also the Chair of the Herbert Wertheim College of Medicine, Coral Gables, FL and the team physician for the Florida Panthers hockey team and the Miami Dolphins football team.

Dr. Uribe authored a study published in JSES International reporting results from 39 patients with advanced shoulder arthritis having anatomic shoulder replacement with the OVOMotion Shoulder Arthroplasty System from Anika, a stemless shoulder with an inlay glenoid component. The study demonstrated that treatment with inlay total shoulder arthroplasty resulted in significant functional improvement, pain relief and patient satisfaction at a mean follow-up of 41 months.

To find out more, including Dr. Uribe’s thoughts on the benefits of inlay glenoids vs onlay; the potential acceptance of inlay technology; trends such as the shift to reverse shoulders, site-of-care; and what’s next, click on the video below to listen to the recorded interview (17:36 min). A link to download a complete transcript of the interview is also provided below.

Topics: Orthopedics
Continue Reading
2 min read

Positive YoY Growth Despite Stronger Headwinds: Q222 Total Joints Market Recap

By Lisa Mahan on 9/7/22 9:30 AM

Despite stronger headwinds from slowing elective procedures, supply chain challenges and unfavorable foreign exchange rates, most total joint companies saw positive growth in Q222.

The WW Total Joints Market grew in Q222 despite slowing sequential growth compared to Q122’s growth. A slowdown in elective procedures late in the quarter along with continued supply chain challenges and the effect of foreign exchange rates resulted in stronger headwinds. SmartTRAK notes that several companies reported the carryover of these headwinds into Q3 that could dampen market recovery through year-end.

Among the many topics covered in detail in our comprehensive Q222 Total Joints Market Recap* are:

Continue Reading
3 min read

SNIS 2022: Advancing Stroke Research and Innovation

By Anne Staylor on 9/6/22 8:47 AM

SNIS President Michael Chen, MD discusses advancing stroke research and innovation in an interview with SmartTRAK at SNIS 2022.

Michael Chen, MD, the 2022 President of the Society of Neurointerventional Surgery (SNIS) and a neurointerventionalist at Rush University Medical Center in Chicago, discusses advances in stroke care research and innovation in an interview with   SmartTRAK at the SNIS 19 th Annual meeting held in Toronto, Ontario, Canada July 25-29, 2022. 

To find out more about emerging devices for the treatment of hemorrhagic and acute ischemic stroke, advancing the stroke systems of care, physician practice trends and how manufacturers can further innovate to improve care, click on the following video to listen to the interview (23:47 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
2 min read

Leveling Out: Q222 US Surgical Matrices Market Recap

By Doug Devens on 9/5/22 9:30 AM

Surgical matrices revenue is flat while procedure volumes level out

With elective procedures in the United States mostly back at pre-pandemic levels, the US Surgical Matrices Market returned to what had been normal growth according to SmartTRAK Financial Dashboard. Becton Dickinson* (BD) grew to a 26.9% share, while AbbVie* slipped to second place.

Among the many topics covered in detail in our comprehensive Q222 US Surgical Matrices Market Recap* are:

Topics: Wound Care
Continue Reading
10 min read

What's New in Computer-Assisted Surgery

By Thomas Wallick on 8/30/22 9:39 AM

The first half of 2022 has delivered both positive and negative developments for the Computer-Assisted Surgery industry. Supply chain issues and surges of COVID-19 infections have continued to have significant impacts on revenues. At the same time, enabling tech product launches proceed at a rapid pace, with some robotic procedures accelerating. The following is a sample of recent CAS news and developments from around the world, compiled by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more.

New Products:

  • Globus*

    GMED announced completion of the first clinical cases using Excelsius3D w/ the ExcelsiusGPS platform. The surgeries were completed at MedStar Union Memorial Hospital in MD, Northwest Specialty Hospital in ID & NYU Langone Health in NY.

  • SPNE touted the Q122 limited commercial launch of FLASH Navigation Lumbar Facet Fusion, which facilitates delivery of OsteoStrand Plus DBM Fiber pellets in spine MIS procedures. It is SPNE’s first procedural solution w/ integrated 7D technology. SPNE Q122 Earnings Press Release

Continue Reading
2 min read

Wound Care Diagnostic Aids: Trends to Watch in 2022 and Beyond

By Terry Hayslett on 8/25/22 9:58 AM

SmartTRAK looks at trends in the Diagnostic Aids market for 2022 with an eye on hard-to-heal wounds, regulatory and reimbursement checkpoints and investment deals and financing.

SmartTRAK  sees continued growth in the Diagnostic Aids market driven by the following factors:
  • Hard-to-heal wounds continue to drive resource utilization and cost
  • Clinicians need diagnostic tools to help guide more efficient and effective product selection
  • Companies are making incremental progress navigating regulatory and reimbursement checkpoints
  • Investors see potential value as evidenced by deals and financing

In 2007, the World Union of Wound Healing Societies (WUWHS) published a consensus document on the Principles of Best Practice in Diagnostics and Wounds. The authors identified the need for new diagnostic tests to help identify why some wounds do not respond to advanced therapies. The document further suggested that the ideal diagnostic tool can detect and quantify biomarkers that impact wound healing, such as molecules, biofilms, oxygen content and temperature changes. SmartTRAK looks at trends in the Diagnostic Aids market in 2022 with a focus on ...

To download and read the complete article "Wound Care Diagnostic Aids: Trends to Watch in 2022 and Beyond" just click the button below. Download the Article

Topics: Wound Care
Continue Reading
3 min read

Acandis Inc: Targeting the US Market for Neurointervention

By Anne Staylor on 8/23/22 9:00 AM

Georg Schauer, PhD, President of Acandis Inc., discusses the Company, its novel devices and targeting the US market for neurointervention in an interview with SmartTRAK at the Society of Neurointerventional Surgery (SNIS) 19th annual meeting held in Toronto, Canada July 25-26, 2022

To find out more about how Acandis plans to differentiate itself and compete in the US market, click on the following video recorded live at SNIS 2022. (11:30 min). A link to download the complete transcript of the interview is also provided below. 

Continue Reading
3 min read

A Mixed Bag of Ups & Downs: Q122 CAS Ortho Recap

By Shelly Caruso on 8/19/22 9:30 AM

Q122 proved to be a mixed-bag of ups and downs with supply chain issues and Covid surges having varying impacts on market leaders’ performance amidst a strong wave of enabling tech product launches.

The Q122 WW CAS Ortho Market was down according to SmartTRAK Financial Dashboard. Stryker* remained the market leader, followed by Zimmer Biomet* and Smith & Nephew*. For detailed Q122 revenues and shares by company in the US, EU and ROW, see the SmartTRAK CAS Ortho Financial Dashboard.

Among the many topics covered in detail in our comprehensive Q122 CAS Ortho Market Recap* are:

Continue Reading
4 min read

BiologicsMD: Targeted Treatments for Bone Disorders and Hair Loss

By Freddy Buntoum on 8/16/22 9:47 AM

Mr J. David Owens, President & CEO of BiologicsMD, and Chief Scientific Officer, Dr. Robyn Goforth, discuss the Company’s highly-targeted therapies, a series of recombinant fusion proteins designed to treat hair loss and severe bone disorders, in an interview with SmartTRAK.

In an interview with SmartTRAK, BiologicsMD President & CEO J. David Owens and CSO Dr. Robyn Goforth discuss BiologicsMD’s innovative highly-targeted treatments for severe bone disorders and hair loss diseases.

To find out more about this early-stage company, the science behind highly-targeted therapies, and two of its lead compounds, click on the following video to listen to the full interview (29:10 min). A link to download a complete transcript of the interview is also provided below.

Continue Reading
2 min read

A Solid Recovery: Q122 Spine Market Recap

By Courtney Sheedy on 8/11/22 9:37 AM

Q122’s year-over-year growth in the WW Spine market shows normalized, nominal growth for this quarter, which should continue to improve over the course of the remaining year.

The US Spine Hardware market saw double-digit growth versus Q121, showing solid recovery gains from the same period prior year, which seemed to be riddled with ongoing volatility. Segment over segment within the spine market, we’re back to seeing growth in the areas that had been predicable growth segments prior to COVID-19. Although healthcare as a whole continues to rebuild, and staffing remains a challenge, many regions didn’t experience as negative an impact on the Spine market for Q122 as was predicted by many.

Among the many topics covered in detail in our comprehensive Q122 Spine Market Recap* are:

Continue Reading
3 min read

R92 Medical: Reimagining the Road to Stroke Interventions

By Anne Staylor on 8/9/22 9:30 AM

Adam Hattan, VP of Marketing for Route 92 Medical, discusses the Company, its novel system for mechanical thrombectomy and competing in the market for stroke interventions in an interview with SmartTRAK at SNIS 2022.

Amid a growing number of me-too devices, one company that is differentiating itself in the market for stroke thrombectomy is Route 92 Medical (R92). Adam Hattan, R92’s vice president of marketing, discusses R92’s novel system for mechanical thrombectomy and competing in the market for stroke interventions in an interview with SmartTRAK at the Society of Neurointerventional Surgery (SNIS) 19th Annual Meeting held in Toronto, Canada July 25-29, 2022.

To find out more about R92, its Monopoint operating platform and the Company’s strategies for growth, click on the following video recorded live at SNIS 2022.  (10:13 min). A link to download a transcript of the interview is also provided below.

Continue Reading
2 min read

New Spine Enabling Technologies: Q122 CAS Spine Market Recap

By Shelly Caruso on 8/5/22 12:15 PM

Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accelerate, and companies continue roll out new spine enabling technology and strategize how to maximize the remainder of 2022.

The Q122 WW CAS Spine Market was up year-over-year according to SmartTRAK Financial DashboardMedtronic* (MDT) remained the market leader with 59.5% share, followed by Globus* (GMED) and other enabling tech competitors, including Stryker* (SYK) and Brainlab*

Among the many topics covered in detail in our comprehensive Q122 CAS Spine Market Recap* are:

Continue Reading
2 min read

The Future of Biosensors and Smart Dressings in Wound Care Diagnostics

By Kris Flinn on 8/2/22 9:30 AM

Could biosensors and smart dressings be the final frontier in wound diagnostics? SmartTRAK explores the current progress of this market and how it could develop.

It has been 15 years since the World Union of Wound Healing Societies’ Initiative published a consensus document entitled “Diagnostics and Wounds.” Since then, the clinical practice around assessing and diagnosing wounds has not evolved at the same rate as that of treatments. At the same time, the need for improved wound diagnostics has never been greater given burgeoning chronic wound numbers and the continued shift of wound care services to the outpatient setting.

Could the next area of development be that of biosensors and smart dressings? SmartTRAK believes there is increasing evidence that this could be the case. In this article, we explore the developments that are taking place, how the identification of infection biomarkers may be lucrative and ways the market may change in the coming years.

Among the many topics discussed in this article are:

Topics: Wound Care
Continue Reading
2 min read

Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap

By Natasha Weeks on 7/28/22 9:30 AM

Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisitions were plentiful and regulatory clearances show promise of future new product introductions.

Continue Reading
6 min read

Diagnostic and Digital Devices on Display: WOCNext 2022

By Gary Delhougne on 7/25/22 10:21 AM

Emerging from the COVID-19 era, wound care innovation is driven by small players, especially in the digital and diagnostic spaces

In June, wound, ostomy and continence-focused nurses, and supporting industry gathered in Fort Worth, TX for the hybrid WOCNext 2022 conference. In-person attendance was below expectations, but healthy booth time allowed for product discussions with exhibitors.

SmartTRAK observed that product innovation at WOCNext came from smaller companies and those focused on digital and diagnostic solutions not large manufacturers like Smith+Nephew*, 3M* or Mölnlycke*SmartTRAK learned that the large manufacturers are not launching new products for multiple reasons, including supply chain limitations, access to raw materials and the confidence to be able to supply enough products to serve the market.

SmartTRAK is closely watching advances and innovation in the digital and diagnostic space in wound care. Specifically, SmartTRAK Analyst Kris Flinn recently published an article, "The Future of Biosensors and Smart Dressings in Wound Care Diagnostics", available here, highlighting developments in diagnostic biosensors in smart dressings. Additionally, in an early 2022 interview with reimbursement expert Kathleen Schaum, we learned about reimbursement trends that support the development and use of these products. 

Outlined below are several wound diagnostic and digital products prominently highlighted at WOCN.

Topics: Wound Care
Continue Reading
2 min read

Trends in Neurovascular Innovation 2022

By Shelly Caruso on 7/21/22 9:30 AM

Improved aspiration systems, large-bore catheters, balloon-guide catheters and radial access top the list of neurovascular device trends that will continue in 2022.

In the market for mechanical thrombectomy devices, the pace of innovation shows no signs of slowing down in 2022. Manufacturers are designing neurointerventional devices with an eye toward improving first-pass effect, recanalization rates and reducing procedure times to ultimately improve patient outcomes In this article, SmartTRAK highlights recent trends in neurovascular technologies, including variable pressure aspiration systems, large-bore catheters (LBCs), balloon-guide catheters (BGCs) and radial access, as key areas of innovation moving into 2022.

Along with the recent trends in neurovascular technologies, the following topics are covered in detail in this article, which is available for download here:

  • Outgrowing Standard Aspiration Systems
  • Continued Trend Toward Large-Bore Catheters for Access and Aspiration
  • New Designs and Applications for Balloon-Guide Catheters
  • Increasing Competition in Radial Access
Continue Reading
2 min read

SmartTRAK Tip: How to Discover Gaps in your Company's Portfolio

By Thomas Wallick on 7/18/22 9:30 AM

Imagine if you could…
  • See gaps in your product portfolio vs your competitors’ 
  • Discover your next acquisition candidate
  • Find a distribution partner

…in just a few clicks!

BE THE EXPERT who fills in the gaps in your company's portfolio! Read on to view a "How To" video and learn how to outperform your peers and competitors by saving yourself HOURS of research with just ONE search.

That’s the power of SmartTRAK!

For example…

Continue Reading
2 min read

Ending on a Bright Note: Q122 OrthoBio Market Recap

By James Petricek on 7/14/22 9:30 AM

Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached pre-pandemic levels.

Virtually all orthopedic/spine companies experienced the same pattern with elective procedures during the quarter. In general, elective procedure case counts were pressured in January through the beginning of February as a surge in COVID-19 cases impacted patients and contributed to staffing shortages at healthcare facilities. However, by the end of the quarter elective procedures approached or returned to pre-COVID levels.

Among the many topics covered in detail in our comprehensive Q122 OrthoBio Market Recap* are:

Continue Reading
3 min read

Partnering for Success in Neurovascular: Wallaby Medical

By Anne Staylor on 7/12/22 9:30 AM

Wallaby Medical CEO and founder Michael Alper discusses the Company’s recent acquisition of phenox GmBH and positioning the Company for success in an interview with SmartTRAK

With no overlap from a product or geographic perspective, Wallaby Medical’s recent acquisition of phenox GmBH was a “match made in heaven” according to Wallaby’s CEO and founder Michael Alper. In an interview with SmartTRAK, Alper discusses the acquisition, company synergies, complementary channels and the Company’s strategies for global expansion and becoming a leader in the market for neurovascular intervention.

To find out more, including details about the acquisition, the Company and its key products and markets, click on the following video to listen to the interview recorded via Zoom (21:07 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
2 min read

Springing Back: Q122 US Joint Fluid Replacement Market Recap

By Freddy Buntoum on 7/8/22 9:30 AM

US Viscosupplementation Market players march on the positive momentum of Q421 and Q122, putting the spring back into their steps.

For Q122, US Joint Fluid Replacement market players continued on a running growth, which did not seem too disrupted by the COVID Omicron variant. Furthermore, some players shared that despite physicians’ offices not yet running at 100% levels, company sales representatives were able to hold face-to-face visits and secure new orders.

Among the many topics covered in detail in our comprehensive Q122 US Joint Fluid Replacement Market Recap* are:

Continue Reading
3 min read

STIMVIEW XT: A New Approach to DBS Programming

By Anne Staylor on 7/7/22 9:30 AM

Rafael Carbunaru, PhD, Boston Scientific’s VP of R&D, discusses DBS therapy and STIMVIEW XT, the Company’s new advanced visualization software for DBS programming, in an in-depth interview with SmartTRAK at INS 2022

Rafael Carbunaru, PhD, vice president of research and development for Boston Scientific (BSX), discusses deep brain stimulation (DBS) and STIMVIEW XT, the Company’s new advanced visualization software for DBS programming in an in-depth interview with SmartTRAK at the International Neuromodulation Society (INS) World Congress in Barcelona, Spain held May 21-26.

Used with the Vercise Genus DBS portfolio and developed in collaboration with Brainlab, STIMVIEW XT uses patient-specific 3D visualization of patient anatomy and enables clinicians to see, shape and steer DBS therapy using point-and-click interface designed to simplify programming, save time and better personalize therapy.

To find out more about STIMVIEW XT, DBS workflows and BSX’s vision for DBS, click on the following video to listen to the interview recorded live at INS 2022 (45:16 min). For more details, interview topics by timecode are provided below. A link to download a complete transcript of the interview is also available below.

Continue Reading
1 min read

SmartTRAK Reports from Paris: EWMA 2022

By Lennart Stadler on 7/5/22 9:30 AM

SmartTRAK reports that challenging conditions lead to minimal innovation in Paris.

It was third time lucky for the approximately 3,500 attendees of the 2022 European Wound Management Association (EWMA) conference in Paris. Although not yet back to a pre-pandemic number of participants, it was encouraging to see an international presence without the barrier of COVID-19 restrictions. Previous dates in 2020 and early 2022 fell to the pandemic, so great credit goes to the organizers and exhibitors for persevering and delivering a positive and engaging event.

Among the many topics covered in this SmartTRAK perspective article, which you can download here, are:

  • MDR Consuming R&D Resources
  • Clouds over Germany - Is There a Silver Lining?
  • Establishing a European Foothold
  • The Trend in Using Fewer Layers in Compress
Topics: Wound Care
Continue Reading
2 min read

A Bumpy Ride: Q122 Spinal Cord Stimulation Market Recap

By Anne Staylor on 6/30/22 9:30 AM

Q122 SCS Market revenues were up in the low-single digit YoY, but pandemic-related issues made it a bumpy ride

For Q122, the spinal cord stimulation (SCS) market was up in the low-single digits YoY in both the US and WW, but pandemic-related issues made it a bumpy ride. The market was down from pre-pandemic levels for most competitors, still weakened by pandemic disruption, staffing issues and a limping recovery. 
 

Among the many topics covered in detail in our comprehensive Q122 Spinal Cord Stimulation Market Recap* are:

Continue Reading
2 min read

Alternative Posterior Fixation: An Interview with Rick Simmons at ISASS 2022

By Courtney Sheedy on 6/28/22 9:30 AM

Spinal Elements provides an in-depth look at the Company’s novel Karma Fixation System and what’s next for the technology at ISASS 2022

Spinal Elements Chief Marketing Officer Rick Simmons provides SmartTRAK an indepth look at the Company’s Karma Fixation System, a low-profile alternative to traditional pedicle screw technology, at the International Society of the Advancement for Spinal Surgery (ISASS) 2022 Annual Conference held June 1-4 in the Bahamas. Karma implants consist of a high-performance polymer, enabling an almost completely radiolucent approach to stabilizing the lumbar spine, as an adjunct to fusion and are designed to engage more predictably strong cortical bone. Click on the following video to find out more and see a demonstration of the current technology (7:00 min).

Continue Reading
2 min read

New Product Offerings in a Busy Quarter: Q122 Extremities Market Recap

By Lisa Mahan on 6/24/22 9:27 AM

The return of elective procedure volumes, new product offerings and a busy first quarter of acquisitions all supported healthy growth for the Extremities Market

While growth drivers varied for specific companies in Q122, the return of elective procedure volumes helped drive double-digit growth for several market players. Stryker*, the Extremities Market leader, benefited from the return of elective procedures in the US. Its US Foot & Ankle and Upper Extremities business segments contributed to the Company’s US Trauma & Extremities growth during the quarter. Stryker also noted during its earnings call that ...

Among the many topics covered in detail in our comprehensive Q122 Extremities Market Recap* are:

Continue Reading
2 min read

Soft Tissue Fixation Rebounds: Q122 Market Recap

By Andy Knapik on 6/22/22 11:10 AM

Soft Tissue Fixation Rebounds in Q122

After a slow end to 2021, Soft Tissue Fixation bounced back with procedure volumes rebounding in the first quarter of 2022. With 2021 being a year of ups and downs due to the COVID pandemic, staffing shortages and supply chain issues, the start of 2022 looked to be no different. However, even though the quarter started off a bit sluggish, it picked up steam quickly and ended on a positive note with worldwide Soft Tissue Fixation revenues up +7.5% over Q121.

Among the many topics covered in detail in our comprehensive Q122 Soft Tissue Fixation Market Recap* are:

Continue Reading
3 min read

Opportunities in Neuromodulation: Abbott at INS 2022

By Anne Staylor on 6/20/22 10:11 AM

Ryan Lakin, Abbott DVP of R&D, discusses opportunities in neuromodulation in an interview with SmartTRAK at INS 2022

Continue Reading
2 min read

Revenues on the Rise: Q122 US Surgical Matrices Market Recap

By Doug Devens on 6/17/22 12:34 PM

Surgical matrices procedures appear back to near pre-pandemic levels, with revenues on the rise

With elective procedures in the United States mostly back at pre-pandemic levels, the US Surgical Matrices Market returned to what had been normal growth in Q122, gaining +5.7% YoY according to SmartTRAK Financial Dashboard. AbbVie* continued to lead the Surgical Matrices Market, though it was approximately flat, while Becton Dickinson* (BD) grew strongly.

Among the many topics covered in detail in our comprehensive Q122 US Surgical Matrices Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

Moving Past COVID: Q122 WW Advanced Wound Care Market Recap

By Gary Delhougne on 6/16/22 9:38 AM

WW Advanced Wound Care growth settles to a traditional mid-single digit growth rate as global wound care moves past COVID-19.

Topics: Wound Care
Continue Reading
2 min read

The Effect of Clinical Trial Investment On Hernia Matrices Revenues

By Doug Devens on 6/14/22 9:30 AM

SmartTRAK investigates recent trends in hernia repair clinical trials and how these trends relate to competition in the hernia repair market. Using a new SmartTRAK tool to analyze data in clinicaltrials.gov, SmartTRAK describes shifting trends in hernia repair research with company-sponsored studies and randomized controlled trials (RCTs)

Topics: Wound Care
Continue Reading
2 min read

SmartTRAK is Seeking an Account Manager-Customer Success

By Ray Luzi on 6/10/22 10:12 AM

Are you looking for a position that gives you a big picture view of everything that is going on in the world of life sciences? Do you have business experience in the medical device industry? If so, we would love to talk with you.

We are BioMedGPS, the creators of the SmartTRAK platform. We are the leading strategic advisory and healthcare analytics provider in the life sciences industry. Our team is once again expanding and seeking an Account Manager who can grow with us. The Account Manager will be responsible for creating and maintaining strategic relationships with our medical device clients. Learn More and Apply

Continue Reading
2 min read

Procedure Volume Recovery Isn't The Only Trend: Q122 Total Joints Market Recap

By Lisa Mahan on 6/9/22 9:30 AM

Procedure volume recovery is not the only trend on SmartTRAK’s radar

Procedure volume recovery continues to be a trend on everyone’s radar from industry execs to healthcare providers. In Q122, the Knee Replacement Market in the US seemed to experience a much stronger recovery than Hips based on YoY growth rates, according to SmartTRAK Financial Dashboard. However, Knees faced a much easier YoY comp as more knee procedures were postponed in Q121 compared to hips due to their more elective nature. Putting this into perspective, US Hip Market growth along with Knees reinforced the feeling that 2022 procedures will be closer to “normal” as the Total Joints Market recovers from the downsizing caused by COVID.  And, as the industry’s bandwidth for focusing on the pandemic decreases, the emphasis on other trends grows.

Among the many topics covered in detail in our comprehensive Q122 Total Joints Market Recap* are:

Continue Reading
4 min read

INS 2022 Interview with Dr. Marc Russo: Dorsal Horn Dendrite Stimulation for SCS

By Anne Staylor on 6/7/22 9:30 AM

Dr. Marc Russo discusses dorsal horn dendrite stimulation, a new paradigm for SCS, and making it available to all manufacturers in an interview with SmartTRAK at INS 2022

Dr. Marc Russo, president of the International Neuromodulation Society (INS), presented exciting new research on dorsal horn dendrite stimulation (DHDS), a new paradigm for spinal cord stimulation (SCS), at the INS 15th World Congress, held May 21 to 26, 2022 in Barcelona, Spain. In an interview with SmartTRAK, Dr. Russo discusses the proposed mechanism of action for DHDS compared to traditional dorsal column stimulation, six-month study results in 27 patients and what’s next in terms of his research. 

And, in an unprecedented move, Dr. Russo decided not to patent DHDS and said he is giving the novel waveform as a “gift” to physicians, industry and patients, noting that it is deployable on all current SCS devices within the product range. To find out more about DHDS, including its characteristics and Dr. Russo’s vision for a more advanced version that could theoretically even “cure pain,” click on the video below of the interview conducted shortly after his presentation outside the Barcelona International Convention Centre (12:02 min). A link to download the  complete transcript of the interview is also provided below.

Continue Reading
4 min read

WUWHS – A Hybrid Wound Care Event with a Local Touch in Abu Dhabi

By Lennart Stadler on 6/2/22 10:44 AM

WUWHS – a hybrid event with a local touch

Back Into the Water
After having been postponed several times, the World Union of Wound Healing Societies (WUWHS) finally took place in Abu Dhabi in early March and SmartTRAK was there. Mölnlycke* came in hot, launching Avance Solo* in the region, whereas most other companies were represented by local distributors. SmartTRAK noted that the hybrid format was an interesting concept, unfortunately, impacted by technical issues.

The Olympics of Wound Care
WUWHS is similar to the Olympics in the sense that it is an event with a global focus held every fourth year, every time by a new organizer. Like the Olympics, the WUWHS was postponed in 2020 due to COVID-19, the last one was held six years ago, and the pandemic also impacted both attendance and format. A negative COVID test was required both to enter and leave Abu Dhabi, which likely made attendees participate online rather than in person. SmartTRAK estimates that 20% to 30% of the participants were there in person and 70% to 80% participated online. Unfortunately, the event was full of technical issues and there were also many speakers missing when they were supposed to present, which brought down the overall experience for those who attended in person.

Find out how to receive SmartTRAK Daily Updates in your morning email

Mölnlycke Launches Avance Solo in the Region
Mölnlycke overshadowed all other companies at the event. It had the largest exhibition, an Innovation Area lounge, a high international presence, held the most lunch symposia and was the only company doing a major product launch.

The Company launched its ...

Topics: Wound Care
Continue Reading
3 min read

Leveraging Government Affairs for Commercial Success: An Interview w/ Jack Kalavritinos

By Gary Delhougne on 5/26/22 9:30 AM

Jack Kalavritinos, Former HHS/FDA Senior Official and Principal of JK Strategies, discusses the importance and benefits of government affairs in medtech

Jack Kalavritinos is the Founder and Principal of JK Strategies, a communications and public policy firm that helps organizations develop winning communication and policy strategies. Jack is also a former senior government official and appointee in HHS, FDA and DOL. Jack has decades of Washington, DC government, political and business experience including in the medtech sector with Covidien.

In this interview with SmartTRAK, Jack shares his thoughts on the benefits to medtech commercial leaders of developing collaborative relationships with their government affairs colleagues. Specifically, SmartTRAK’s interview with Jack covers the next phases of the COVID-19 public health emergency, the potential impact of the midterm elections and ways companies can work with the FDA.

To find out more, including Jack’s take on how medtech commercial leaders can develop relationships with their Representatives and Senators, click on the following video recorded live via Zoom. Outlined below are specific interview topics by the minute. To download a complete transcript of the interview, click here.

Continue Reading
2 min read

Meet with SmartTRAK at ISASS 2022

By Thomas Wallick on 5/25/22 10:03 AM

The SmartTRAK team will be attending the upcoming International Society for the Advancement of Spine Surgery (ISASS) in The Bahamas and we would love to schedule some time to meet. We are particularly excited about this year’s conference program and speakers.

Our team of expert analysts have their finger on the pulse on the spine industry trends, news, financial data and competitor developments. We would like to meet to hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.

Watch the video below to meet Courtney Sheedy, SmartTRAK's GM, Spine


Meet Us at ISASS

Build an Enterprise of Experts, so your
Company can build the next big thing.

Continue Reading
10 min read

What’s New in Neuromodulation for Spring 2022

By Anne Staylor on 5/23/22 11:52 AM

In the market for neuromodulation, companies are developing spinal cord stimulation (SCS), deep brain stimulation (DBS) and other stimulation devices designed to treat a vast range of indications. Current and emerging devices are addressing care gaps in the treatment of chronic pain and movement disorders as well as epilepsy, Tourette syndrome, depression, pelvic floor dysfunction, peripheral artery disease, paralysis and spinal cord injuries.

Companies competing in the market for neuromodulation include Abbott*, Boston Scientific*, Medtronic*, Nevro*, Saluda Medical*, Newronika* and Axonics, just to name a few. To keep you up to speed on what’s new in neuromodulation, SmartTRAK highlights market updates covering clinical developments, patents, new research and other top news from Spring 2022.

SmartTRAK's Anne Staylor, Executive Editor, VP &GM of Neurotherapies, is in Barcelona attending the INS 15th Congress.

The following is just a small sampling of recent neuromodulation updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

Clinical Developments

  • Medtronic*
    • Medtronic announced the first patient implanted in its “Evaluation of Long-term Patient Experience with a Medtronic Closed-Loop SCS System” study of its investigative, closed-loop, ECAP-responsive device to treat back and limb pain. The prospective study is enrolling 90 patients across 10 centers in Australia.
    • A University of Florida-sponsored eight patient clinical trial will evaluate DBS to treat Tourette syndrome targeting two brain regions in each hemisphere of each patient and using two leads in each hemisphere connected to two Percept PC devices. Estimated study completion is Aug 2026. clinicaltrials.gov

  •  Boston Scientific*
    • Boston Scientific received FDA approval of its latest image-guided programming software, Vercise Neural Navigator with STIMVIEW XT. Developed in collaboration with Brainlab*, STIMVIEW XT provides real-time visualization of lead position and simulation modeling for Parkinson’s Disease and essential tremor treatment.
Continue Reading
5 min read

Trends in Product and IT-Driven Innovations: SAWC Spring 2022

By Gary Delhougne on 5/19/22 10:56 AM

Emerging from the COVID-19 era, wound care innovation is driven by smaller companies

In April, the Symposium on Advanced Wound Care (SAWC) Spring 2022 returned to an in-person format for the first time since 2019. Though the turnout was below expectations, attendees enjoyed reconnecting with clinicians, engaging with vendors and catching up with colleagues and competitors.

Despite being three years since the last SAWC Spring, large wound care companies like Smith+Nephew* (SNN), Mölnlycke*, 3M* and others were oddly without major product introductions. SmartTRAK has learned that extended FDA review timelines and supply challenges may be playing a significant role in this reality. Companies have publicly commented that innovation and new product launches are planned for 2022, but timelines must have slipped past the SAWC Spring deadlines.

Regardless, innovation was not completely absent from SAWC Spring as smaller companies introduced new products and more companies exhibited IT-driven diagnostic, measurement and data-capture technologies.

(The SmartTRAK team will be attending the upcoming European Wound Management Association (EWMA) event May 23-25 in Paris. We would love to schedule some time to meet and hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.)

In this article, SmartTRAK highlights new products and novel technologies exhibited at SAWC Spring 2022.

Topics: Wound Care
Continue Reading
5 min read

Wound Care Today 2022 – Looking Ahead with Cautious Optimism

By Kris Flinn on 5/17/22 9:00 AM

Increased wound prevalence meets new software and solutions at WCT 2022.

There was a positive energy in the room at the 5th Wound Care Today (WCT) conference as industry and clinicians came together in Milton Keynes. COVID-19 infection rates remain high in the UK but this is not being reflected in hospitalizations or deaths, leading to a national determination to move forward without restrictions. The pandemic has, however, shaped the priorities of those present and in a range of discussions. SmartTRAK encountered a commercial eagerness to make up for lost time and a looming burden of chronic wounds.

The SmartTRAK team will be attending the upcoming European Wound Management Association (EWMA) event May 23-25 in Paris. We would love to schedule some time to meet and hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.

Continue Reading
5 min read

Total Joints: Trends to Watch in 2022

By Lisa Mahan on 5/16/22 10:27 AM

From economics to the ASC shift, SmartTRAK looks at the trends affecting the Total Joints Market

The start of the new year did not play out as so many of us had hoped. Heading into 2022, the next COVID surge reared its ugly head with the Omicron variant storming through countries around the globe. Healthcare facilities once again postponed elective procedures due to capacity issues and/or staff or patients being diagnosed with COVID. Overall inflation rose to a level that hasn’t been seen since the early 1980s. Looking ahead, is there a silver lining in this dark cloud? SmartTRAK believes the forecast is not all doom and gloom. Let’s look at some of the trends affecting the climate of the Total Joints market.

(Continue reading to find out how to receive FREE SmartTRAK DAILY UPDATES)

Continue Reading
2 min read

Trends To Watch in 2022: Injectable Regenerative Medicine Therapies

By Freddy Buntoum on 5/10/22 9:00 AM

From the impact of stringent regulations to the shift toward new indications and rising market segments, SmartTRAK explores some of the trends to watch for in 2022 and beyond.

Orthopedic regenerative medicine therapy as an emerging area of science holds great promise for treating and promoting faster healing in a variety of injuries. There is also a belief among some scientists and industry stakeholders that it may hold the key to halting or reversing degenerative chronic conditions through self-healing. In a previous article, SmartTRAK had highlighted several challenges that Regenerative Medicine therapies would need to overcome to become a fully viable business and recognized treatment solution for patients. In 2021, businesses, societies and health care systems across the world continued to experience disruptions from the COVID-19 pandemic and its subsequent waves of variants. Furthermore, much greater scrutiny and tougher regulations for some of the injectable regenerative medicine therapies were put into place. The start of 2022 is also not quite as “rosy” as most had hoped for ...

Download the complete Injectable Regen Medicine article

Continue Reading
3 min read

Bone Computers that Monitor and Improve Musculoskeletal Health: Osseosurface Electronics

By Nick Fitzpatrick on 5/5/22 12:14 PM

In an interview with SmartTRAK, University of Arizona professor Dr. Philipp Gutruf discusses research on a new class of bioelectronics he calls osseosurface electronics and its application in the orthopedic field. Dr. Gutruf is an Assistant Professor in the Biomedical Engineering Department at the University of Arizona and his research group focuses on creating devices that integrate with biological systems by combining innovations in soft materials, photonics and electronics to create systems with broad impact on health diagnostics, therapeutics and exploratory neuroscience. 

To find out more, including the design of this new class of bioelectronics and how Dr. Gutruf believes osseosurface electronics will serve as a diagnostic tool after recovery from surgery, click on the following video to listen to the full interview (11:26 min). A link to the complete transcript of the interview is also provided below.

Topics: Orthopedics
Continue Reading
4 min read

The State of Cybersecurity in Healthcare

By Nick Fitzpatrick on 5/3/22 9:00 AM

Jason Winkler, Sales VP of cybersecurity startup Device Authority, discusses the state of cybersecurity in healthcare in an interview with SmartTRAK.

In an interview with SmartTRAK, Device Authority VP of Sales (Americas) Jason Winkler discusses the state of cybersecurity in healthcare and medical devices.

To find out more, including the devices most vulnerable to cybersecurity threats and how medical device manufacturers should think about designing cybersecurity measures into their connected products, click on the following video to listen to the full interview (17:29 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
3 min read

Real-Time Spinal Navigation: An Interview w/ Pathkeeper Surgical's CEO Erez Lampert

By Nick Fitzpatrick on 4/28/22 9:30 AM

Erez Lampert, CEO and Founder of Israeli start-up Pathkeeper Surgical, discusses the Company’s real-time spinal navigation system that’s generating high interest from ASCs in an interview with SmartTRAK 


In an interview with SmartTRAK, Pathkeeper Surgical CEO and Founder Erez Lampert discusses Pathkeeper’s mobile, light-weight spinal navigation system. 

To find out more, including the timeline for FDA approval and demand from surgeons, hospitals and ASCs, click on the following video to listen to the full interview (22:29 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
5 min read

Supply Chain and Inflationary Pressures Weigh on Wound Care Companies

By Gary Delhougne on 4/26/22 8:30 AM

Macroeconomic headwinds are projected to continue through the first half of 2022.

Supply chain headaches and inflationary pressures significantly impacted wound care companies in 2021. Though Advanced Wound Care revenue rebounded +11.5% in 2021 according to SmartTRAK’s Financial Dashboard, it was not without strong headwinds of higher input costs, logistical nightmares and labor shortages.

To understand how these macroeconomic trends affected wound care companies, SmartTRAK reviewed quarterly and fiscal year earnings reports from FY21 to see how various wound care companies reported the company-specific impact. From troubles sourcing materials to higher input costs and the need to raise prices, SmartTRAK uncovered a consistent trend of macroeconomic pressures affecting many global and regional wound care manufacturers.

Be The Expert in Wound Care -  Click for FREE SmartTRAK Updates for 30 Days

Topics: Wound Care
Continue Reading
1 min read

Wallaby Acquires phenox GmBH

By Anne Staylor on 4/21/22 6:41 PM

Wallaby Medical announced it has acquired phenox GmbH, including phenox's femtos GmbH, a German-based neurovascular company, for a total of ~$545MM (EUR 500MM) including milestone payments. SmartTRAK previously reported the possibility of the acquisition deal in early March 2022. Wallaby Medical acquiring phenox GmbH is one of the largest recent cross-border transactions in the medical device industry and will enable the Company to provide a wide range of neurovascular solutions to pts in the US, China, Europe, Japan and other international markets.

For more information about phenox, click to read "phenox Takes Aim at US Market with Novel Stroke Devices", SmartTRAK's interview with James Lago, President and CEO of phenox Inc., in which he discusses the Company's novel mechanical thrombectomy device and flow diverter, and what’s next in terms of bringing these technologies to the US market.

Continue Reading
4 min read

Innovators Target Pediatric Hips: Just for Kids

By Lisa Mahan on 4/19/22 8:30 AM

Dr. Mark Figgie, Hospital for Special Surgery, and Nick Deeter, Founder & CEO WishBone Medical discuss their journey to develop a pediatric-specific hip replacement system in an interview with SmartTRAK

Dr. Mark P. Figgie, Chief of Surgical Arthritis Service at Hospital for Special Surgery (HSS) in New York City, and Nick Deeter, Founder and CEO of WishBone Medical discuss their collaboration on the development of the first off-the-shelf hip replacement system for pediatric patients in an interview with   SmartTRAK. Dr. Figgie shares how his 30-year experience with complex joint replacements, many in juvenile patients, led to his collaboration with WishBone medical to create a hip system specifically tailored for pediatric and young adult patients.

To find out more, including the indications for a pediatric hip replacement, the global market implications, and the next steps Dr. Figgie and WishBone will be taking to bring this hip system to the market, click on the video below to listen to the recorded interview (17:53 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
3 min read

Abbott: Expanding the Ecosystem in DBS - An Interview with Binith Cheeran

By Anne Staylor on 4/13/22 9:50 AM

Abbott’s Binith Cheeran, MD, PhD discusses the latest trends in DBS as well as the Company’s strategies for growth in an interview with SmartTRAK

Binith Cheeran, MD, PhD, Abbott’s senior director of medical and clinical affairs for deep brain stimulation (DBS), discusses the latest trends, research and innovation in DBS in an interview with SmartTRAK. Abbott is focused on growing the market through patient education, improving access to care through its NeuroSphere Virtual Clinic and expanding the ecosystem in DBS through the Company’s connected devices.

To find out more, including Dr. Cheeran’s thoughts on primary cell vs rechargeable devices, use of specific image guidance systems, closed-loop DBS and empowering patients through digital health solutions, click on the video below to listen to the interview recorded online via Zoom (32:45 min). A link to download the transcript of the interview is also provided below.

Continue Reading
5 min read

Trends & Technologies in Total Joints: AAOS 2022

By Lisa Mahan on 4/11/22 9:32 AM

New products and signs of procedural recovery lighten the mood at AAOS 2022

The mood at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting was upbeat despite scaled-back attendance and exhibit space. Surgeons and exhibitors alike were excited to get back to in-person discussions about issues in orthopedics, new products hitting the market and the potential for recovery from the impact of COVID. While at the meeting, SmartTRAK met with industry professionals from clinicians to company representatives identifying key takeaways from market drivers and limiters to new product introductions.

(Continue reading to find out how to receive FREE SmartTRAK DAILY UPDATES)
Continue Reading
2 min read

Strong Gains with Room to Grow: Q421/FY21 AWC Market Recap

By Gary Delhougne on 4/7/22 9:41 AM

Advanced wound care delivers strong double-digit growth and still has room to grow.

The WW Advanced Wound Care markets regained their form in FY21 as wound care recovered globally after COVID-19 impacted FY20. Advanced Dressings delivered nearly double-digit growth, with Wound Biologics and External Devices also reporting excellent revenue growth vs FY20.

Among the many topics covered in detail in our comprehensive Q421/FY21 AWC Market Recap* are:

Continue Reading
9 min read

SAWC Know Before You Go: Wound Care News and Updates

By Thomas Wallick on 4/4/22 10:46 AM

In just a few days, the first SAWC Spring meeting since the start of the pandemic is set to begin. SmartTRAK has been tracking all the developments in the Wound Care market as the world changes, including how the market has responded to unprecedented times, what new therapies and treatments are being produced and when things might return to a “new normal. The following is a small sampling of SmartTRAK’s Wound Care news updates from the past week to help get you ready for the conference and Be the Expert who makes a difference in the industry.
 
Our SmartTRAK analysts have been compiling, reviewing and posting daily breaking news and developments from the global Wound Care industry. If you’d like to discuss some of these insights, you can also meet up with us at SAWC. Even if you’re not attending, you can sign up for 30 days of Free SmartTRAK Updates and a 15-minute Crash Course.
 

New Products:

  • Cardinal Health* 

    Cardinal Health announced the launch of the first surgical incise drape using Chlorhexidine Gluconate (CHG). The drape features Avery Dennison's patented BeneHold CHG adhesive technology, which helps reduce the risk of surgical site contamination w/ organisms associated w/ SSIs.

  • Coloplast is gradually launching Alprep Pad in select markets. Now available in the UK, Australia and New Zeeland. Alprep Pad is a foam for mechanical cleansing and debridement of wounds.

Continue Reading
2 min read

New Products Offset COVID Headwinds: Q421/FY21 Trauma Market Recap

By Natasha Weeks on 3/31/22 9:30 AM

New product introductions offset slightly weaker Q4 results due to COVID-19 headwinds and international pressure.

While the Trauma segment was not impacted as heavily due to COVID-19 headwinds, companies that play within the space were impacted by deferrals of elective surgeries such as limb restoration. Long bone trauma volumes remained healthy as players cited new product introductions as growth drivers for the segment. 

Among the many topics covered in detail in our comprehensive Q421/FY21 Trauma Market Recap* are:

Continue Reading
2 min read

The Future is Today in Remote Patient Monitoring: An Interview with Scott Laster

By Gary Delhougne on 3/28/22 9:30 AM

Scott Laster, CEO and co-founder of MiCare Path, discusses the present and future of monitoring patients between office visits in an interview with SmartTRAK

Scott Laster is the CEO and co-founder of MiCare Path, a leading platform to connect patients with their providers between visits. Scott is a medical device industry veteran with 15+ years of experience in the trenches launching products and supporting clinicians. In this interview with SmartTRAK, Scott shares his thoughts on the benefits of monitoring patients between office visits, the evolution of reimbursement of remote monitoring and where MiCare Path is going in the future.

To find out more, including Scott’s take on how MiCare Path benefits orthopedic and wound care patients and clinicians, click on the following video recorded live via Google Meet (17:04 min). Specific interview topics by timecode are outlined below. To download a complete transcript of the interview, click here.

Continue Reading
2 min read

Taking a Hit: Q421/FY21 Soft TIssue Fixation Market Recap

By Andy Knapik on 3/25/22 9:28 AM

Soft Tissue Fixation Takes A Hit In Q421

After two quarters of significant growth, Soft Tissue Fixation took a hit in Q421, with another spike in COVID cases negatively affecting procedure volumes. 2021 was a year full of ups and downs due mainly to the COVID pandemic and Q4 was no different. COVID once again brought a new wave of cases, with the Omicron variant taking its toll on Soft Tissue Fixation case volumes resulting in modest YoY revenue declines over 2020.

Among the many topics covered in detail in our comprehensive Q421 Soft Tissue Fixation Market Recap* are:

Continue Reading
10 min read

The Week in Orthopedic Research & Development - March 22, 2022

By Thomas Wallick on 3/22/22 9:30 AM

As the world continues to adapt to the "new normal", even with the possibility of a new variant ahead, SmartTRAK keeps calm and carries on, reporting daily on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma. And, if you are in Chicago for the big Orthopedics conference this week, make sure you visit us at Booth #4350, or you can schedule a meeting with us...just click here.

SmartTRAK features curated content by our team of industry experts, bringing the most relevant information and insight directly to you in real time. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos and interviews.

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

  • Nexxt Spine* 

    Nexxt Spine launches a product-line extension to the NEXXT MATRIXX 3D Printed Porous Titanium portfolio of implants indicated for use in stand-alone ALIF procedures, which features Nexxt Spine’s proprietary 3D laser printed titanium technology. LinkedIn.com

  • DePuy Synthes announced two new additions to its Attune Knee line, Attune Cementless Fixed Bearing Knee w/ AFFIXIUM 3D porous coating (tibial component) and Attune Medial Stabilized Knee.(medial stabilized fixed-bearing insert), that can be used with other Attune components.

  • On FY21 performance, Biogennix’s CEO Chris MacDuff also mentioned the Company saw increasing sales for its newest product, Agilon Moldable, esp in the F&A surgery market. The company also continued to see consistently strong growth of Agilon Moldable in the spine market segment.

Patents:

  • Medtronic*

    Warsaw Orthopedic’s US Patent Application “SPINAL IMPLANT WITH FEATURES FACILITATING INDEPENDENT EXPANSION OF PORTIONS THEREOF & METHOD FOR USE THEREOF” was published describing an implant which facilitates adjustment of lordotic/kyphotic &/or coronal angulation. 20220079770

  • One-Way Adjustable Loop Suture Constructs  

    US Patent “One-Way Adjustable Loop Suture Constructs And Methods Of Forming And Using The Same” was issued describing surgical constructs & methods of use for a one-way adjustable fixation loop for a fixation device, such as a cortical button or plate.11,272,920

  • Acumed’s US Patent Application “HEADLESS COMPRESSION SCREW HAVING AN ATTACHMENT MECHANISM” was published describing a cannulated headless compression screw w/ an attachment mechanism that enables coupling various attachments to the screw. 20220079642

Topics: Orthopedics
Continue Reading
2 min read

Losing Steam Due to COVID: Q421/FY21 Spinal Cord Stimulation Market Recap

By Anne Staylor on 3/18/22 9:30 AM

Spinal Cord Stimulation companies had a strong start in Q421 but the market lost steam as the Omicron variant surged

Despite a strong start for all SCS competitors in Q421, the SCS market started to run out of steam late in the quarter as the contagious Omicron variant surged around the world, slowing elective procedures and resulting in a YoY low-single-digit decrease in SCS revenue in both the US and WW.  For the full year (FY), US and WW SCS revenues were up in the low-double-digits driven by strong YoY results in Q121 and Q221 in which COVID trends improved against easy comps in Q120 and Q220. 

Among the many topics covered in detail in our comprehensive Q421/FY21 Spinal Cord Stimulation Market Recap* are:

Continue Reading
1 min read

2022 Outlook for US Breast Matrices: Recent Trends and Future Impact

By Doug Devens on 3/15/22 8:00 AM

SmartTRAK examines recent trends in breast implants and discusses their future impact on breast matrices.

Breast matrices, whether acellular dermal matrices (ADMs) or biosynthetics, have enabled improved outcomes in implant-based breast reconstruction and have contributed, in large part, to the revival of the prepectoral breast reconstruction technique. As the number of breast implant procedures has grown, so has the use of breast matrices. However, SmartTRAK believes the side effects and health consequences now associated with breast implants, while rare, will negatively impact breast implant usage and thus reduce the growth rate of breast matrices in 2022 and beyond.

In this informative Outlook article by Doug Devens, SmartTRAK's Product Director and Senior Editor, Wound, Doug covers:

  • The Relationship between Breast Surgery and ADM Usage
  • Trends in Implant Usage
  • Recent Concerns that May Affect Breast Implant Usage
  • The Future Outlook for 2022 and Beyond
Continue Reading
3 min read

Meet The Expert: Beth Roach, Account Manager, Customer Success

By Thomas Wallick on 3/14/22 10:28 AM

We are pleased to announce that Beth Roach has joined the team at SmartTRAK as our new Account Manager, Customer Success. The SmartTRAK Customer Success team ensures that our users are realizing the maximum benefit from the platform. The team is a central point of contact for users, in addition to the existing SmartTRAK Sales and Analyst teams, and provides complimentary training (refresher or new user) in person or via video.

If you'd like to discuss your SmartTRAK account with Beth, please reach out to her and she'll be happy to support you.

Meet Beth Roach:

What is your role with SmartTRAK? Account Manager, Customer Success

What do you like about SmartTRAK? There is just so much information all in one place. All news, company profiles, market sizing, product portfolio comparison and so much more all at your fingertips!

Topics: Meet The Team
Continue Reading
2 min read

What's New in Wound Care Reimbursement 2022: An Interview w/ Kathleen Schaum

By Gary Delhougne on 3/4/22 11:36 AM

Kathleen “Kathy” Schaum, President of Kathleen D. Schaum & Associates, discusses her thoughts on the impact of COVID-19 on wound care and reimbursement.

Kathy is a “go-to” provider of wound care reimbursement information, education and strategy to manufacturers and providers. In this interview with SmartTRAK, Kathy shares her thoughts on the impact of COVID-19 on the delivery and reimbursement of wound care and the advancements in remote monitoring, diagnostics and sensors. To find out more, including Kathy’s take on skin substitute/CTP trends, click on the following video recorded live via Google Meet (25:13 min). Specific interview topics by time code are outlined below. A link to the complete transcript of the interview is also provided below.

Continue Reading
2 min read

Q421 Market Recap: US Surgical Matrices

By Doug Devens on 3/3/22 12:55 PM

Procedures using surgical matrices continued their recovery and companies have resumed investing, with revenues surpassing their Q419 levels. 

As the pandemic wanes and procedures are again being scheduled, the US Surgical Matrices market grew strongly in Q421, gaining +12.7% YoY according to the SmartTRAK Financial Dashboard. AbbVie continued to lead the Surgical Matrices market, with Becton Dickinson also growing well ...

Among the many topics covered in detail in our comprehensive Q421 US Surgical Matrices Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

A New View: AI-Driven Imaging

By Elise Wolf on 3/1/22 9:23 AM

In this article, SmartTRAK reviews the development of AI in healthcare and profiles four companies implementing AI-driven imaging in these spaces.

The US Orthopedic Computer-Assisted Surgery (CAS) Market is one of the fastest-growing markets in orthopedics and is expected to reach revenues of $1.14B by 2025, according to SmartTRAK estimates. The Orthopedic CAS market includes a range of enabling technologies including robotic platforms, navigation systems, surgical planning tools, augmented/virtual reality technology and artificial intelligence (AI). AI is being increasingly incorporated into diagnostics and planning to assist in optimization of surgical decision making and anomaly detection.
 
The prominence of AI and machine learning technologies in medicine has snowballed over the past decade. Diagnostic Imaging and navigation is experiencing a new paradigm of technology through the emergence of AI-driven 3D reconstruction, segmentation and navigation applications. Two areas seeing quick implementation and adoption of these new systems are orthopedic planning/navigation and neurovascular diagnostics. In this article, SmartTRAK reviews the development of AI in healthcare and profiles four companies implementing AI-driven imaging in these spaces.

Download the complete AI-Driven Imaging article

Continue Reading
3 min read

NANS 2022: What's New for Abbott Neuromodulation

By Anne Staylor on 2/28/22 11:11 AM

Abbott’s Allen Burton, MD discusses the Company’s new MRI labeling, expanded payer coverage for DRG, big data and digital initiatives in an interview with SmartTRAK at NANS 2022

Allen Burton, MD, Abbott Divisional Vice President, Medical Director Neuromodulation, discusses Abbott’s latest research and innovation in an interview with SmartTRAK at the North American Neuromodulation Society (NANS) Annual Meeting held January 13-14, 2022.

To find out more, including about the Company’s new MRI labeling, UnitedHealthCare coverage for DRG, big data and the status of Abbott’s digital initiatives, click on the video below to listen to the interview recorded live at NANS 2022. (30:18 min.) A link to download a complete transcript of the interview is also provided below.

Continue Reading
4 min read

Medtronic: The Future of Neuromodulation in 2022 and Beyond

By Anne Staylor on 2/22/22 9:30 AM

Medtronic Neuromodulation executives Dave Anderson and Charlie Covert discuss the Company and the future of neuromodulation in an interview with SmartTRAK at NANS 2022

Dave Anderson, Medtronic’s President Neuromodulation, and Charlie Covert, Vice President and General Manager of Pain Therapies, discuss the Company, pandemic and the future of neuromodulation in a wide-ranging interview with SmartTRAK at the North American Neuromodulation Society (NANS) 25th Annual Meeting held January 12-15, 2022 in Orlando, Florida.

To find out more about the Company’s newest innovations, expanding indications*, clinical research and strategies for driving growth in spinal cord stimulation (SCS) and deep brain stimulation (DBS), click on the following video recorded live at NANS 2022. (33:45 minutes.) Specific interview topics by time code are also outlined below. To download a complete transcript of the interview, click here.

Continue Reading
3 min read

An Interview with Nevro's D. Keith Grossman

By Anne Staylor on 2/16/22 10:00 AM

D. Keith Grossman, chairman, CEO and president of Nevro Corporation, discusses the Company, expanding indications and driving growth through innovation and evidence in an interview with SmartTRAK

Nevro’s Keith Grossman expects randomized controlled trials and recent FDA approvals for expanded indications--painful diabetic neuropathy (PDN) and non-surgical refractory back pain (NSRBP)--to provide a competitive edge and help drive growth in the market for spinal cord stimulation (SCS). To find out more, including Grossman’s take on Medtronic’s recent FDA approval for the diabetic peripheral neuropathy (DPN) indication, click on the following video recorded live* via Google Meet (40:20 min). Specific interview topics by time code are also outlined below. If you would like to download a complete transcript of the interview, please click here.

Continue Reading
2 min read

Current and Emerging Trends in Hernia Outcomes Research

By Doug Devens on 2/11/22 9:30 AM

SmartTRAK highlights current and emerging trends in hernia outcomes research presented at the European Hernia Society – Americas Hernia Society Joint Congress held in Copenhagen.

by Doug Devens - Sr Analyst, Biosurgery, IT Product Director

Changes in hernia regulations and evolving views on how to study the performance of hernia matrices have fueled a growing interest among hernia researchers in using different methods and data sources to measure outcomes associated with these devices. In this article, SmartTRAK highlights current and emerging trends in hernia outcomes research presented at the European Hernia Society – Americas Hernia Society Joint Congress (Hernia2021), in Copenhagen, including the increasing use of registries and their relative advantages and disadvantages compared to the gold standard randomized controlled trial (RCT). ­

Topics: Wound Care
Continue Reading
10 min read

The Week in Orthopedics Research & Development

By Thomas Wallick on 2/10/22 9:30 AM

As the world slowly adapts to the "new normal",  SmartTRAK continues to report daily on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma. And, if you are going to Chicago for the big Orthopedics conference in March, visit us at Booth #4350 or you can schedule a meeting with us...just click here.

SmartTRAK features curated content by our team of industry experts, bringing the most relevant information and insight directly to you in real time. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos and interviews.

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

  • Journey ll* - Smith+Nephew*

    Smith+Nephew announced the first completed surgery using its JOURNEY II Medial Dished (MD) System for total knee arthroplasty. The procedure was performed by Dr. Ran Schwarzkopf, Orthopedic Adult Hip and Knee Reconstruction at NYU Langone Health.

  • Zimmer Biomet is anticipating the launch of Persona* cementless knees later in 2022 incorporating a design for improved press-fit fixation. The Company has < 10% penetration in cementless w/ runway ahead for the new knee to take off. ZBH Q421 Earnings Transcript on Unhedged.com

  • On FY21 performance, Biogennix’s CEO Chris MacDuff also mentioned the Company saw increasing sales for its newest product, Agilon Moldable, esp in the F&A surgery market. The company also continued to see consistently strong growth of Agilon Moldable in the spine market segment.

Patents:

  • CONMED* 

    Conmed’s US Patent Application “Dual Expansion Anchor” was published describing a suture anchor with an expanding function for biceps tenodesis. 20220039792

  • Expandable Intervertebral Device

    A US Patent Application “EXPANDABLE INTERVERTEBRAL DEVICE,” submitted by the Moskowitz Family, LLC of Rockville, MD was published describing a universal zero-profile expandable intervertebral spacer device for fusion & distraction throughout the entire spine. 20220039963

  • Howmedica Osteonics’ US Patent Application “ORTHOPEDIC SURGICAL PLANNING BASED ON SOFT TISSUE AND BONE DENSITY MODELING” was published describing virtual surgery planning using a mixed-reality headset display. 20220039868

Topics: Orthopedics
Continue Reading
5 min read

SmartTRAK’s 2022 Outlook for the US Skin Substitute/CTP Market

By Gary Delhougne on 2/8/22 9:30 AM

From Site of Care Migration to the Impact of Reimbursement Changes SmartTRAK evaluates market trends to watch for in 2022.
by Gary Delhougne, GM Wound

The Skin Substitute/CTP (Cellular and/or Tissue-based Products) market is undergoing significant growth and change. Reimbursement motives, COVID-19 and clinician site of care decisions had a profound impact on the market in 2020 and 2021. The growth outlook for 2022 remains strong as providers and industry adapt to unique market conditions.

SmartTRAK estimates the 5-year CAGR (compound annual growth rate) through 2025 for Skin Substitutes/CTP products to be in the mid to high single digits. In 2020, industry revenue surpassed $1B and SmartTRAK expects the market to pass $1.5B by 2025.

To better understand the impact of site of care changes, SmartTRAK launched a new subscription module specifically covering site of care changes occurring in the Skin Substitute/CTP market. It’s SmartTRAK’s fastest-growing new product offering and you can learn more by clicking here.

As SmartTRAK looks to 2022, we see three trends to consider for the Skin Substitute/CTP market –

Continue Reading
3 min read

Meet The Expert: Kris Flinn, Analyst, Wound Care

By Thomas Wallick on 2/7/22 1:37 PM

We are pleased to announce that Kris Flinn has joined the team at SmartTRAK as an analyst in Wound Care. Kris has 20+ years of experience within wound care, including Smith & Nephew. Kris recently ran a consultancy focusing on assisting med device companies with commercial strategies. He is based in England.

Meet Kris Finn:

What is your role with SmartTRAK? I’m an analyst within the wound team, with a particular focus on NPWT in Europe.

What do you like about SmartTRAK? The quality of the information and analysis produced is excellent, and something which does not exist anywhere else. All of the team members are true experts in their field, and have the experience and networks to prove it.

What is something special or unique that you bring to SmartTRAK subscribers?

Continue Reading
1 min read

ConvaTec Acquires Triad Life Sciences, Cites SmartTRAK in Press Release

By Thomas Wallick on 2/1/22 9:30 AM

SmartTRAK, the leading source of competitive intelligence used by the top ten global orthopedic wound care companies, was once again cited as a trusted source, this time in ConvaTec's press release "Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc" published January 28th.

ConvaTec, in the press release, stated that it was " ...

Continue Reading
2 min read

Emerging Leaders in Regen Med: A Talk with Jointechlabs' CEO Nathan Katz

By Freddy Buntoum on 1/31/22 2:56 PM

Jointechlabs – Emerging leader in point-of-care regenerative and rejuvenation medicine therapies

Nathan Katz PhD, ALBB, Co-founder, CEO and Chief Technical Officer at Jointechlabs* (JTL) discussed the Company’s unique technology platform and product developments in a recent interview with SmartTRAK.

Download the Nathan Katz Interview Transcript

JTL is a privately-held regenerative medicine solutions company based in North Barrington, IL. As an emerging leader in point-of-care regenerative and rejuvenation medicine therapies, JTL has patented, portable medicine products that enable personalized therapies. The Company’s lead product, MiniTC*, is an FDA-cleared portable medical device for isolation of fragmented and purified fat grafts (microfat) at the point-of-care. Additionally, JTL is developing therapies for unmet medical needs, with its first product candidate, JTL-T-01*, a proprietary injectable stem cell scaffold in clinical development as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program.

SmartTRAK: Can you first tell us a little bit about yourself and then about Jointechlabs?

Nathan Katz: I have a medical background. I graduated from medical school back many years ago in Russia, then graduated from Tel Aviv University and acquired my Master’s Degree and PhD in Cell Biology. I came to the US 16 years ago, first, working on genetics and embryonic stem cells. I spent quite a lot of time in research with embryonic stem cells in the first decade of this millennia and then I was looking for the technology that could be translated into applicable medical technology and translated into therapy.

Adult stem cells came up as the first and obvious choice to look at more precisely, so we shifted, and I shifted personally, my focus from embryonic stem cells towards adult stem cells. I came across PadZuke, and Patricia, who published the first publication on actual adipose-derived stem cells in 2001. My idea was that it is the right way to go and could lead to ...

To read the entire interview with Dr. Katz, please click the button below to download the complete transcript.Download the Nathan Katz Interview Transcript


SmartTRAK is the leading source of competitive intelligence used by the top ten global wound care & orthopedics companies. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Continue Reading
2 min read

Meet The Expert: Tracey Clarke, Account Manager, Customer Success

By Thomas Wallick on 1/31/22 11:37 AM

We are pleased to announce that Tracey Clarke has joined the team at SmartTRAK as our new Account Manager, Customer Success. Tracey has 20+ years experience in the Print and Digital Communications industry, including roles as a Client Relations Manager and IT Project Manager at Broadridge Customer Communications and DST Output LTD.

Meet Tracey Clarke:

What is your role with SmartTRAK? I am an Account Manager on the newly established Customer Success team.

What do you like about SmartTRAK? This is an exciting time to be starting at SmartTRAK. There are many positive changes happening and I am enjoying the opportunity to see the outcome. I feel very fortunate to be with a company that helps others Be the Expert.

Continue Reading
5 min read

SmartTRAK's Top 10 Blog Posts of 2021

By Thomas Wallick on 1/25/22 9:30 AM

Despite the seemingly never-ending COVID-19 epidemic, SmartTRAK continued to keep you informed of everything that transpired in the MedTech industry in 2021. As the leading provider of real-time market data and analysis for the orthopedic, wound, regenerative medicine and neuro therapies markets, SmartTRAK is uniquely suited to make you the expert on all the latest developments. Our knowledgeable analysts covered a lot of ground, everything from breaking medical device event coverage to interviews with some of the industry's top thought leaders.

Here are SmartTRAK's Top 10 blog posts of the past year that garnered the most attention from you and your colleagues, plus 3 bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!

Trends in OrthoBiologics & Regenerative Medicine: A Surgeon's Perspective
by Freddy Buntoum

In this wide-ranging interview with SmartTRAK, Dr. Wasik Ashraf, an Orthopaedic Surgeon specializing in Sports Medicine, gives his view of CMS' FY21 OPPS-ASC Final Rulemaking, and discusses emerging trends and innovation in OrthoBiologics and Regenerative Medicine.

Continue Reading
2 min read

Smith+Nephew Cites SmartTRAK in Engage Surgical Acquisition Press Release

By Thomas Wallick on 1/21/22 9:30 AM

SmartTRAK was cited as a source in a press release from Smith+Nephew* entitled "Smith+Nephew acquires novel cementless partial knee system."

Smith+Nephew, in the release, announced that it has acquired Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the US. The article cited SmartTRAK's reporting that "the partial knee market is currently worth approximately $300 million in the US".

The press release goes on to say that "This acquisition strongly supports Smith+Nephew’s strategy for growth by transforming its business through innovation and acquisition, while also providing differentiation for its customers. The Engage Surgical Partial Knee System is a novel, modern cementless knee implant to serve a resurgent segment driven by the potential for better long-term fixation through biologic integration, shorter operating times, and the shift to Ambulatory Surgery Centers (ASCs)."

Randy Kilburn, Exec VP & GM, Reconstruction, Robotics and Digital, added:

“Smith+Nephew is now the only medical device company offering both cemented and cementless partial knee implants in the US, as well as robotics-assistance through the CORISurgical System that is well-suited for the precise alignment needed .... The acquisition will drive Smith+Nephew’s Robotics and Real Intelligence strategy. Partial knee procedures are well-matched for robotics due to the need for precise alignment and Smith+Nephew’s CORI Surgical System already supports the cemented JOURNEY II unicompartmental knee. The Engage Surgical Partial Knee System is optimised for robotics and will have an application with CORI in the future. Engage Surgical’s Partial Knee System also complements Smith+Nephew’s focus on serving the growing outpatient market, with an increasing proportion of knee procedures performed in ASCs."


Used by the leading orthopedic and wound care companies, SmartTRAK is the premier provider of competitive intelligence, including market data, analysis and advisory services for the orthopedic, wound, regenerative medicine and neuro therapies markets. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click the button below.

Learn More

Continue Reading
3 min read

Meet The Spine Expert: Courtney Sheedy, GM, Spine

By Thomas Wallick on 1/18/22 9:30 AM

We are pleased to announce that Courtney Sheedy has joined the team at SmartTRAK as our new General Manager, Spine. Courtney has 15+ years of Global Marketing and Product Development experience dedicated to the spinal medical device market serving in leadership roles for companies like Zimmer Biomet, Alphatec, Corelink and joimax.

Meet Courtney Sheedy:

What is your role with SmartTRAK? General Manager, Spine

What do you like about SmartTRAK? I’m fortunate to have been a user of SmartTRAK for many years prior to joining the ranks as a GM. I love how dynamic the SmartTRAK platform is. For Marketing and Business Development teams to be able to access real-time market information to guide their pipeline planning and day-to-day marketing strategies is one of the most unique and beneficial attributes. I also love how user-friendly the platform is. As a former marketer, I loved the ability to export data files for direct use.

Continue Reading
2 min read

COVID Halts Elective Surgeries: Q321 Spine Market Recap

By Nick Fitzpatrick on 1/14/22 10:15 AM

The Spine Market was down in every category as Covid halted elective spine cases globally. 

Spine market performance in Q321 was mired by the resurgence of the Covid-19 Delta Variant, both in the US and OUS. All markets were down sequentially YoY, with dynamic devices taking more than a double digit hit globally.

Globus’ potential takeover of Nuvasive was the biggest storyline of Q3, as they search to gain market share through acquisitions. Market participants are certainly taking note of Globus, as Medtronic CEO Geoffrey Martha stated they are trying to attract Globus users with the launch of their Catalyft Expandable Interbody System.

Among the many topics covered in detail in our comprehensive Q321 Spine Market Recap* are:

Continue Reading
5 min read

Duramesh: MSI’s Novel Suturable Mesh: An Interview w/ Gregory Dumanian, MD

By Doug Devens on 1/11/22 8:00 AM

In an interview with SmartTRAK, Mesh Suture, Inc. (MSI) Founder Gregory Dumanian MD, discusses the Company and its novel suturable mesh that has the potential to change how hernias and other conditions are treated.

MSI is commercializing a novel suturable mesh that combines a mesh’s ability to distribute forces and support tissue with the precise placement and minimal foreign body presence of a suture. In a time when patients and physicians are rethinking how mesh is used in hernia treatment, MSI’s Duramesh offers the potential of retaining the durability of mesh repair with less foreign body presence. Today, the Company is running clinical trials and building evidence to support regulatory clearance in the United States. To find out more about the Company and its operation, SmartTRAK talked with Gregory Dumanian, MD, Chief of Plastic Surgery at Northwestern University’s Feinberg School of Medicine, Founder & Medical Officer of MSI and the inventor of the new technology.

Click on the following video to listen to SmartTRAK Senior Analyst Doug Devens’ interview with Dr. Dumanian, which was recorded via Zoom audio (24: 35 min). A link to download a complete transcript of the interview is also provided below.

Topics: Biosurgery
Continue Reading
2 min read

Regaining its Pre-Pandemic Stride: Q321 US Hemostats & Sealants Market Recap

By Doug Devens on 1/7/22 9:30 AM

The US market for Hemostats and Sealants regained its pre-pandemic stride in Q321 as many procedures mostly returned to normal volumes.

Continue Reading
3 min read

Solving Healthcare Issues w/ Blockchain Technology: An Interview with John Bass

By Nick Fitzpatrick on 1/4/22 8:00 AM

Hashed Health CEO John Bass discusses how Hashed Health is bringing blockchain technology to healthcare in an interview with SmartTRAK

In an interview with SmartTRAK, Hashed Health CEO John Bass discusses the Company and the use case of blockchain and distributed ledger technology in the medical device industry. Hashed Health is a venture product studio that partners with healthcare and life science enterprises to introduce new blockchain-based healthcare solutions to market.

To find out more, including why blockchain technology is important for medical device manufacturers, click on the following video to listen to the full interview (25:42 min). A link to download the complete transcript of the interview is also provided below.

Topics: Top Story
Continue Reading
2 min read

Overcoming Pandemic Hurdles: Q321 CAS Spine Market Recap

By Shelly Caruso on 1/3/22 11:16 AM

Covid-related challenges continued to dampen market recovery in Q321. Despite pandemic hurdles, technology that improves surgical precision and real-time workflows is driving adoption and innovation in computer-assisted spine surgery and accelerating the development of products and systems.

Many companies with established enabling technologies are pushing to expand indications for existing systems and bolster them with robust preoperative planning, enhanced navigation and post-op evaluation solutions for start-finish integration within a single line of products. Meanwhile, other players are focusing on open-platform solutions to address care gaps for specific procedures and populations. At the forefront of industry research and development are artificial intelligence and virtual reality technologies to aid in imaging, planning and navigation assistance (robotic-assisted and freehand). 

Among the many topics covered in detail in our comprehensive Q321 CAS Spine Market Recap* are:

Topics: Spine CAS Spine
Continue Reading
2 min read

COVID-19 Headwinds: Q321 OrthoBio Market Recap

By James Petricek on 12/29/21 11:49 AM

Renewed COVID-19 headwinds mute overall Q3 results, however, the soft tissue repair segment remains resilient

Impact of the Delta variant was felt broadly across OrthoBio, with virtually all publicly traded companies observing a reduction in surgical volume (relative to forecast) directly attributable to a resurgence of COVID-19. Overall, OrthoBio revenue declined, primarily driven by a sharp reduction in Bone Replacement revenue. Several companies noted the decrease in surgical volumes was most acute in August and September due to shortages in hospital staffing. Weakness was most closely tied to deferrable, elective, complex spine procedures.

Among the many topics covered in detail in our comprehensive Q321 OrthoBio Market Recap* are:

Continue Reading
2 min read

Riding the Wave of Healthy Growth: Q321 Trauma Market Recap

By Natasha Weeks on 12/27/21 4:01 PM

Trauma market continues to ride the wave of healthy growth with positive returns for current players and new players start to stir the waters

Trauma players rode the wave of another quarter of healthy returns as trauma procedures were not as impacted by the rise in the Delta variant as its elective procedure counterparts. The Trauma Market closed Q3 up +4.5% YoY compared to Q320, with the US up +5.8% YoY.

Among the many topics covered in detail in our comprehensive Q321 Trauma Market Recap* are:

Topics: Trauma
Continue Reading
2 min read

Continued Rebound: Q321 Advanced Wound Care Market Recap

By Gary Delhougne on 12/22/21 12:00 PM

Advanced Wound Care (AWC) continues to rebound in 2021 with growth from US Skin Substitutes and WW Advanced Dressings despite weakness in NPWT.

The WW Advanced Wound Care (AWC) market grew +6.5% YoY in Q321, according to the SmartTRAK Financial Dashboard.

The WW AWC market is made up of a diverse array of wound care products comprising the segments of Advanced Dressings, Wound Biologics and External Devices. WW Advanced Dressings grew in Q3, driven by robust gains in Foams, Antimicrobials and Superabsorbents. WW Wound Biologics showed continued gains among US Skin Substitute market leaders. WW External Devices (of which NPWT makes up 96%) was mostly flat due to delta variant headwinds and low elective procedure volumes slowing growth.

Among the many topics covered in detail in our comprehensive Q321 Advanced Wound Care Market Recap* are:

Topics: Wound Care
Continue Reading
3 min read

OsteoCentric Technologies: Optimizing Implant Fixation

By Nick Fitzpatrick on 12/13/21 9:00 AM

OsteoCentric Technologies' CMO Gavin Sontag discusses the Company and its OssiMI mechanical integration technology in an interview with SmartTRAK.

Gavin Sontag, CMO of OsteoCentric Technologies, discusses OsteoCentric's OssiMI platform technology, company growth rates and plans for expansion in an interview with SmartTRAK. To find out more, including why OsteoCentric acquired an SI-Fusion system, click on the following video. A link to download the complete transcript of the interview is also provided below.

Continue Reading
2 min read

Bursting Bubbles: Q321 Joint Fluid Market Recap

By Freddy Buntoum on 12/9/21 9:00 AM

Q321 results were a letdown compared to the previous quarter as COVID-19 continues to burst HA players’ bubble but hopes for a return to normal prevail.

Spring 2021 brought on much relief to the US Joint Fluid Replacement market and the summer looked promising for a return to normal business conditions. However, as more cases of COVID-19 Delta variant were reported, especially in key hyaluronic acid (HA) states, like Texas and Florida, companies were left as though their bubble got burst. Some players expressed concerns that volumes could be depressed for Q421 since it does not seem to be picking up as fast as they projected. But, for Q321 and for the most part, the majority of HA market players did report positive revenue increases in the third quarter.

Among the many topics covered in detail in our comprehensive Q321 US Joint Fluid Replacement Market Recap* are:

Continue Reading
8 min read

Recent Ortho News & Developments: OSET 2021 Know Before You Go

By Gabriele Nichols on 12/7/21 9:00 AM

As a tumultuous year comes to a finish, the orthopedic industry prepares to gather one last time and close out the year. The Orthopedic Summit once again comes to the Bellagio in Las Vegas, Nevada to bring together the top names in the industry. SmartTRAK will be attending OSET 2021 from December the 11th through the 14th. We've put together an overview of recent Orthopedic news highlights to get you up to speed before the meeting. If you'd like to meet with us in person, please reach out.

The following is just a small sampling of recent Orthopedics related news and updates from around the world compiled, reviewed and posted in real time every day by the expert analysts at SmartTRAK.

Markets:

  • Needham Ortho Surgeon Expert Call Highlights
    During a call co-hosted by Needham, Hip and Knee surgeon Dr. Richard Berkowitz of Tamrac, FL, noted COVID accelerated the shift of recon procedures to the outpt setting w/ ~10-20% of his procedures outpt to increase to ~40-50% over the next few yrs. Needham Ortho Expert Call

  • Knee Market Leaders See Share Gains in Q321
    According to SmartTRAK Financial Dashboard, US knee replacement implant market leader Zimmer Biomet* saw improved market share sequentially in Q321 compared to Q221. Stryker* also experienced an increase in share compared to Q221.

  • OTA 2021 Updates

    DePuy Synthes* showcased their long awaited 3.5/4.5 VA-LCP Periprosthetic Femur Plate*. According to SmartTRAK discussions, the periprosthetic plate spans the femur and is currently in limited launch w/ ~50 sets in the field and full set rollout to commence next year.

Find out how to receive SmartTRAK Daily Updates in your morning email

Topics: Wound Care
Continue Reading
2 min read

Q321 Market Recap: US Surgical Matrices

By Doug Devens on 12/6/21 2:00 PM

Procedures using surgical matrices maintained their new normal, with broad strength in both hernia and breast matrices.

Procedures using surgical matrices maintained their new normal, though the resurgence of Delta variant across the northern tier of states may put a dent in the market following deferrals of procedures in various regions as the COVID-19 Delta variant caused more procedural headwinds.

Among the many topics covered in detail in our comprehensive Q321 US Surgical Matrices Market Recap* are:

Continue Reading
2 min read

Shattered Dreams: Q321 Total Joints Market Recap

By Lisa Mahan on 12/2/21 9:00 AM

Covid-19 Delta surges shatter dreams of strong Q321 market recovery

Surges in COVID-19 Delta cases shattered any dreams of a strong Q321 Total Joints market recovery. Postponement of elective procedures in various areas of the US again negatively impacted Companies pushing out hopes for a return to normal into 2022. In addition to procedure recovery challenges, China’s Volume-Based Procurement program that aims to reduce implant pricing may headwind to the WW Total Joints market in the coming year.

Among the many topics covered in detail in our comprehensive Q321 Total Joints Market Recap* are:

  • Complete Q321 Total Joints Market Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • Total Joints News including Revenues, Data, Charts and Shares
  • US Market Growth Comparison Q321 vs Q319
  • New Products Hitting the Stage
  • Q321 Regulatory Highlights 
Topics: Orthopedics
Continue Reading
2 min read

AAOS 2021: COVID Recovery and ASC Trends

By Lisa Mahan on 11/30/21 9:00 AM

What seems to be on everyone’s mind – COVID-19 recovery and ASC trends

The COVID-19 pandemic reduced the attendance at the 2021 American Academy of Orthopedic Surgeon (AAOS) annual meeting to an estimated 1/5 th of its usual number. Many international surgeons found themselves under travel restrictions while some US surgeons were asked by their institutions to forego the meeting. The pandemic also impacted the conversations taking place on the convention floor with two topics seeming to be top of mind – the recovery from COVID-19 and the ongoing move of joint replacement procedures to the outpatient setting.

At AAOS 2021, SmartTRAK spoke with clinicians and industry executives to obtain their view regarding the pandemic and recovery from COVID-19. Although speculation varied depending on individual circumstances,  some companies and healthcare institutions shared that supply chain issues are holding back the increase in business while others are facing regional shutdowns of elective procedures due to the surge of the Delta variant.

Continue Reading
2 min read

Meet Ray Luzi - Vice President, Customer Success

By Thomas Wallick on 11/29/21 5:00 PM

We are pleased to announce that Ray Luzi has joined the team at SmartTRAK as Vice President of Customer Success. Ray has 25+ years' experience in guiding customer engagement and success with leadership roles at Broadridge as Senior Director of Client Relations and DST OUTPUT Limited.

Meet Ray Luzi:

What is your role with SmartTRAK? I will be joining the team as Vice of President of Customer Success.

What is something special or unique that you bring to SmartTRAK subscribers? My background has been in account management in customer communications. I have built strong relationships with my customers based on transparency and the ability to deliver solutions. I have been extremely fortunate to work with talented individuals who are passionate about servicing our customers.   I look to continue to foster that approach with SmartTRAK.
Topics: Meet The Team
Continue Reading
2 min read

SAWC Fall 2021 - The Return of In-Person Wound Care Conferences

By Gary Delhougne on 11/22/21 10:00 AM

Clinical and industry attendees return to in-person conferences but product launches were limited.

It has been more than two years since the last in-person Society for Advancement of Wound Care (SAWC) meeting and based on attendance at this year’s meeting in Las Vegas (October 29-31), wound care clinicians and exhibitors were ready to be live and in person again.

SmartTRAK returned to the conference in person too and walked the exhibit floor, attended symposia and talked to exhibitors and clinicians to understand the latest trends in the US market for Advanced Wound Care, which is projected to reach
* by 2025E according to SmartTRAK estimates. Two dominant takeaways emerged from SAWC Fall 2021, including the enthusiastic return of in-person wound conferences and only a limited selection of new product introductions.

Topics: Wound Care
Continue Reading
2 min read

Meet Shelly Caruso - Market Analyst/Medical Writer

By Thomas Wallick on 11/19/21 10:00 AM

We are pleased to announce that Shelly Caruso has joined the team at SmartTRAK as a Market Analyst/Medical writer. Shelly has 8+ years in clinical healthcare, 4+ years neurosurgical and orthopedic intraoperative nursing working with medical devices at trauma centers and outpatient facilities, including cranial, spine, sports med, total joint and extremity. Shelly has a BA in economics and BSN in nursing and is a certified editor and member of The American Copy Editors Society.

Continue Reading
3 min read

Start Up Spotlight - Panther Orthopedics: Superelastic Orthopedic Fixation Devices

By Nick Fitzpatrick on 11/16/21 9:00 AM

Silicon Valley-based Panther Orthopedics provides nitinol superelastic fixation devices for the orthopedic trauma and sports medicine markets

Panther Orthopedics is an orthopedic medical technology company focused on developing superelastic fixation devices for trauma and sports medicine applications. The company’s first product, the PUMA system, is the only FDA-cleared superelastic fixation device and is indicated for syndesmosis fixation, hallux valgus reconstruction, and tarsometatarsal fixation. The PUMA System is the first and only FDA cleared superelastic fixation device that maintains continuous compression without creep.

Topics: Orthopedics
Continue Reading
3 min read

Meet Amy Johannson - QC Manager

By Thomas Wallick on 11/12/21 9:37 AM

We are pleased to announce that Amy Johannson has joined the team at SmartTRAK as QC Manager. Amy has broad B2B industry experience leading teams in driving quality results across complex projects including previous roles at AutoWeb and Kelley Blue Book.

Meet Amy Johannson:

What is your role with SmartTRAK? I was just brought on board full time as the QC Manager. Prior to this I was a QC Auditor helping to bring consistency to all our Company and product profiles.

What do you like about SmartTRAK? SmartTRAK is one of the most collaborative and supportive environments I’ve ever worked in. Ideas are heard and thoughtfully considered. The level of detail that goes into these profiles is tremendous and it shows the dedication the staff has to their work.

Topics: Meet The Team
Continue Reading
2 min read

Pushing the Envelope: Q221 CAS Spine Market Recap

By Elise Wolf on 11/11/21 11:26 AM

Enabling tech continued to assist above-market growth in Q221 with continued demand for spine robotics and navigation systems. New developments in augmented reality, artificial intelligence and smart instruments continue to push the envelope in the spine space.

The WW Spine CAS market, the US Spine Robotics market and the US Spine Navigation market were all up significantly in Q221 according to SmartTRAK Financial DashboardMedtronic* (MDT) remained the market leader with > 50% share, followed by Globus* (GMED) and other enabling tech competitors including Brainlab*DePuy Synthes* (JNJ) and Stryker* (SYK). For detailed Q221 revenues and shares by company in the US, EU and ROW, see the SmartTRAK CAS Spine Financial Dashboard*

Among the many topics, including company revenues, market shares, charts and expert analysis, covered in the comprehensive Q221 CAS Spine Market Recap* are:

Topics: Spine CAS Spine
Continue Reading
3 min read

OsStic: Adhesive Technology for Ortho & Beyond - An Interview w/ CEO Philip Procter

By Lisa Mahan on 11/5/21 9:27 AM

Philip Procter, CEO of GPBio & Co-founder of Biomimetic Innovations, shares the OsStic journey of discovery and its path to commercialization in an interview with SmartTRAK

Philip Procter started on a quest several decades ago to solve trauma hardware failure in patients through the development of an adhesive solution. The journey began in earnest after a UK meeting with craniomaxillofacial surgeons facing difficult problems they felt could only be solved with an adhesive technology in combination with implants. Procter was convinced early on that the adhesive solution would have to come from nature studying everything from gecko-based technology to sticky frogs in Australia to Mytilus edulis (common mussel) food protein. But it was after demonstrating the potential of a prototype glue in Sweden in 2014 that his journey led him to become a faculty member of the University of Uppsala, Sweden, and he and his partner Dr Gerard Insley working together with Professor Håkan Engqvist and a team of students developed the technology that is known today as OsStic: a technology with the potential to join implant to bone, bone to bone, soft tissue to bone, and soft tissue to soft tissue.

GPBio and PBC Biomed, both Irish-based companies, joined forces in 2020 to develop and commercialize the OsStic bone adhesive technology through the formation of a new company, Biomimetic Innovations Ltd. Company CEO Philip Procter shared more about the OsStic technology, how it came about and next steps for bringing the product to market in an interview with SmartTRAK’s Lisa Mahan. To find out more about the Company and its operation, click on the following video to listen to the interview, recorded via Uberconference. (17:49 min) A link to download a complete transcript of the interview is also provided below.

Topics: Orthopedics
Continue Reading
2 min read

Robotics Are Heating Up the Market: Q221 CAS Ortho Recap

By Elise Wolf on 11/4/21 1:21 PM

Robotics continued to help fuel growth in orthopedics in Q221 as new products and companies heat up the market and enabling technologies gain momentum across TJR.

Once again, robotics contributed to revenue growth in the orthopedics market in Q221 and competition continues to heat up with several regulatory clearances and other developments from new market entrants in the quarter. Aside from robotics, enabling technology including intra-operative augmented reality, preoperative planning and navigation reached a number of milestones in Q221 across all indications in total joint replacement.

Among the many topics, including company revenues, market shares, charts and expert analysis, covered in the comprehensive Q221 CAS Ortho Market Recap* are:

Continue Reading
4 min read

VIVEX: The Best-Kept Secret in Biologics - An Interview with CEO Peter Wehrly

By Sharon O'Reilly on 10/29/21 8:55 PM

Pete Wehrly, CEO of VIVEX Biologics, discusses the Company and its diverse portfolio in orthopedics and wound care in an interview with SmartTRAK

In an interview with SmartTRAK, VIVEX Biologics’ CEO Pete Wehrly discusses how VIVEX’ diverse portfolio of regenerative solutions in orthopedics and wound care can potentially turn the regenerative medicine industry on its ear with an eye towards proving, through economic and clinical evidence, that its technologies are better than anything on the market today.

To find out more about the Company, its technologies and what’s next in terms of clinical research and reimbursement, click on the following video to see the interview recorded live at the North American Spine Society (NASS) Annual Meeting held in Boston Sept 29 to Oct 2, 2021 (11:24 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
4 min read

A Modern Day Approach for Ordering DME Supplies: An Interview with David Gelbard

By Susan Paquette on 10/29/21 10:56 AM

In an interview with SmartTRAK, Parachute Health CEO David Gelbard discusses the Company and its novel, online DME ordering system for medical devices and supplies that benefit the patient, provider and supplier eliminating the challenges of the ancient fax world.

Parachute Health has implemented a novel, online ordering system that is used for a variety of DME supplies including mobility, sleep therapy and respiratory aids, along with diabetes, wound care, ostomy and urology incontinence supplies. The system benefits the patient, provider and supplier by creating a win, win, win for all and eliminates the challenges of the back-and-forth approval process associated with faxing requests.

In an interview with SmartTRAK, Parachute Health’s CEO, David Gelbard said he founded the Company because his father did not receive an important DME supply after leaving the hospital, causing him to fall at home and requiring additional care. David’s vision for the Company is to establish the infrastructure for DME supplies such that its ease-of-use replicates that of ordering shoes on Amazon or swiping your credit card at a local coffee store. Today, the Company operates across the US at 40,000 different sites of care, from hospitals, nursing homes and doctor’s offices to home health and hospice agencies, and has a network of over 100,000 physicians and prescribers—a number that is rapidly growing. To find out more about the Company and its operation, click on the following video to listen to SmartTRAK’s interview with David Gelbard, recorded via Uberconference (23:35 min). A link to the complete transcript of the interview is also provided below.

Topics: Wound Care
Continue Reading
9 min read

Recent Advanced Wound Care News & Developments: SAWC Know Before You Go

By Thomas Wallick on 10/26/21 9:30 AM

It's time to get out there again and reconnect. SmartTRAK is excited to be attending SAWC Fall, the Symposium on Advanced Wound Care in Las Vegas, Nevada, October 29-31. Gary Delhougne, our new GM,  Wound, will be representing SmartTRAK at the meeting. Please reach out if you would like to meet with Gary in Nevada and see what SmartTRAK can do for you. We've also put together an overview of the latest AWC news to give you a little head start before you get to Vegas.

At SmartTRAK, we constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry. The following is just a small sampling of recent Advanced Wound Care related news and updates from around the world compiled, reviewed and posted in real time every day by the expert analysts at SmartTRAK.

Markets:

  • Advanced Medical Solutions*

    AMS announced that they became part of the NHS Shared Business Services (NHS SBS) framework in the UK w/ their range of advanced wound care dressings. The agreement covers health and corporate services including, e.g., IT, legal, estates & facilities and business services.

  • Foam Dressings in Europe
    Foam is the leading dressing category in the TOP5 EU countries except for Italy, where antimicrobial dressings head up the market in 2020. France owns 36% of the EU Foam market followed by Germany w/ 22%, UK w/ 14%, Spain w/ 8% and Italy w/ 3%. SmartTRAK Europe Market Reports 

  • Winner Medical*
    Winner Medical reported from their participation in the 85th China International Medical Equipment (Autumn) Expo (CMEF) in Shenzhen, China. Winner exhibited their market areas, mainly wound care and infection prevention, for professional care and home care.<

Find out how to receive SmartTRAK Daily Updates in your morning email

Topics: Wound Care
Continue Reading
2 min read

Meet Jim Petricek - General Manager, Orthobiologics & Regenerative Medicine

By Thomas Wallick on 10/25/21 9:26 AM

We are pleased to announce that Jim Petricek has joined the team at SmartTRAK as General Manager, Orthobiologics and Regenerative Medicine. Jim has 20+ years operational and management consulting experience in orthobiologics and regenerative medicine with roles in product development, marketing and business development, including prior management positions with BioMimetic Therapeutics and Synthes.

Meet Jim Petricek:

What is your role with SmartTRAK? General Manager Orthobiologics and Regenerative Medicine; Lead Analyst Orthobiologics

What do you like about SmartTRAK? I’ve had the pleasure of interacting with SmartTRAK for many years. The group is very knowledgeable in their respective fields, and while I’m sure not every day is bliss, there is a very palpable sense that everyone really enjoys being part of the SmartTRAK team.

Continue Reading
6 min read

SmartTRAK's 2021 AOFAS Meeting Highlights

By Natasha Weeks on 10/21/21 9:30 AM

New product introductions and innovative technologies set the stage for AOFAS 2021.

At the American Orthopaedic Foot & Ankle Society (AOFAS) meeting in Charlotte, NC, SmartTRAK identified several key themes and takeaways from the meeting as manufacturers showcased innovation through new product introductions, continue to focus on hallux valgus corrections and the associated instrumentation allowing for reproducible outcomes and the advancements of 3D printed solutions.

The Luster of New Products Help Drive Healthy Foot & Ankle Competition

The foot & ankle space does not look like it is slowing down anytime soon based on the products highlighted at AOFAS. Innovation is helping to drive growth in the US market for Foot & Ankle Repair and Reconstruction, which is projected to reach a 5-year CAGR of +4.9% according to SmartTRAK’s Foot & Ankle Market OverviewNewsworthy highlights include:

Topics: Orthopedics
Continue Reading
3 min read

Evolution is Inevitable: An Interview with Anika's Cheryl Blanchard, PhD

By Freddy Buntoum on 10/18/21 9:37 AM

Cheryl Blanchard, President and CEO of Anika Therapeutics, discusses the Company’s metamorphosis from a partnered, single product company into a customer-facing, global joint preservation market player, in an interview with SmartTRAK.

Cheryl Blanchard, PhD, discusses the Company’s remarkable achievements amid a global healthcare crisis and progress made as Anika continues to execute on its Transformational Growth Strategy and grand plan in an interview with SmartTRAK at the American Academy of Orthopaedic Surgery (AAOS) 2021 in San Diego, California. To find out more, click on the following audio recording. A link to download the complete transcript of the interview is also provided below.

Continue Reading
1 min read

The Debate Over HA Therapy: AAOS 2021

By Freddy Buntoum on 10/15/21 9:48 AM

This Year’s AAOS Annual Meeting was no different--scientific bodies are still divided on the efficacy of HA therapy and it remains a “bête noire” sitting outside of the gold standard for the treatment of patients affected by knee OA.

For some time now, hyaluronic acid (HA) viscosupplement injections (aka intra-articular (IA) HA injections) have become a standard and an integral part of the physician’s armamentarium in the treatment continuum for an ever-growing number of patients suffering from knee osteoarthritis (OA). With OA universally established as the most prevalent form of arthritis afflicting the US population, SmartTRAK estimates that approximately 2.3 million HA injection procedures will be performed for knee OA alone.  Yet, confusion and debates persist over the efficacy of HA therapy, product composition and source of the HA, volume and number of injections, treatment cost and, more recently, regulatory classification for HA products. SmartTRAK believes that the plethora of studies on the use of HA injection that show varied results is ...

To download and read the complete article by Freddy Buntoum, Sr. Analyst, Orthobiologics and Regenerative Medicine at SmartTRAK, please click the button below.

Download the Article

Continue Reading
10 min read

OTA Know Before You Go: Recent Trauma News and Developments

By Thomas Wallick on 10/12/21 9:00 AM

With the fresh scent of optimism in the air, it's time to get out there again and re-connect. SmartTRAK is excited to be attending OTA, the Orthopaedic Trauma Association annual meeting in Fort Worth, Texas, October 20-23. Please reach out if you would like to meet in Ft. Worth and see what SmartTRAK can do for you. We've also put together an overview of the latest trauma news to give you a head start for the meeting.

At SmartTRAK, we constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry. The following is just a small sampling of recent Trauma related news and updates from around the world compiled, reviewed and posted in real time every day by our SmartTRAK expert analysts.

Patents:

  • JNJ/DePuy Synthes* 

    DePuy Synthes Products’ US Patent Application “Angled Flutes in Cannulated Bone Screws” was published describing a cannulated bone anchor w/ cutting flutes extending to the distal end of the anchor. 20210307800

  • Adaptive Tibiotalocalcaneal Arthrodesis Nail
    A US Patent Application “ADAPTIVE TIBIOTALOCALCANEAL ARTHRODESIS NAIL - NAIL ADAPTER SYSTEM,” submitted by Amr Abdelgawad of Brooklyn, NY was published describing a tibiotalocalcaneal nail & system that has a plurality of effective interfaces. 20210307794

  • Arthrex was issued US Patent “Low profile dorsal plate” describing devices, systems & methods for direct dorsal fixation of fractures of the distal radius including a low profile dorsal plate. 11,134,996

Continue Reading
1 min read

SmartTRAK is Seeking a Spine Market Analyst

By Sharon O'Reilly on 10/11/21 11:02 AM

We are looking to strengthen our SmartTRAK Spine module with the addition of a qualified person with industry specific experience. All SmartTRAK analysts are former marketing, business development or R&D professionals with one of the major orthopedic/spine suppliers and, in fact, most have come to us via recommendations from our subscribers, as well as those in the industry. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add we can offer SmartTRAK subscribers.

We are looking for person with Spine industry experience who is interested in working approximately 20 hours per week. We would also consider a person who would like to work full-time.Learn More and ApplyIdeally, this person has:

  • Deep knowledge of the spine market, especially spine hardware
  • Strong communication skills, especially writing
  • Good analytical skills and experience with forecasting
  • Attention to Detail
  • Extensive contacts in the industry with both companies and clinicians

This is a great position for an experienced person who wants to remain in the game but wishes to work part-time.

Visit our careers page to apply or request more info.

Topics: Spine
Continue Reading
2 min read

What's on the Horizon? Q221 Spine Market Recap

By Julianne Burns on 10/8/21 9:50 AM

The US Spine market appears to be continuing on a skyward trajectory...but what’s really on the horizon for Spine?

With Q221 year-over-year growth up almost 46%, the US Spine market appears to be continuing on a skyward trajectory. However, as compared to Q219, Q221 saw growth of only +1.3%, reflecting ongoing COVID challenges. What’s really on the horizon for Spine? While the first half of 2021 has certainly looked much brighter than 2020, one big question remains: how big of an impact will the Delta variant surge have on the back half of the year?

Among the many topics covered in detail in our comprehensive Q221 Spine Market Recap* are:

Continue Reading
2 min read

SmartTRAK's New Arthroscopic Technologies Module: An Interview with the Analyst

By Thomas Wallick on 10/6/21 10:00 AM

Our Arthroscopic Technologies module launched earlier this year with a big splash.  We interviewed SmartTRAK's Sr. Analyst for Arthroscopic Technologies, Andy Knapik, to learn more about this new offering.

In the following video, Andy discusses what's included in the module and why we're so excited about this addition to the SmartTRAK platform. To request more information, please click here.

HubSpot Video


"It is my goal to provide detailed and unrivaled data that will allow SmartTRAK’s subscribing partners to better understand the Arthroscopic Technologies market; helping them make informed decisions on resource allocation and innovation that will ultimately lead to more effective and advanced patient care." Andy Knapik

Continue Reading
3 min read

Meet Gary Delhougne - General Manager, Wound

By Sharon O'Reilly on 10/5/21 9:00 AM

We are pleased to announce that Gary Delhougne has joined the team at SmartTRAK as General Manager, Wound. Gary is a licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

Gary will be taking over for Susan Paquette, who is retiring at the end of the year. For the past 10 years, Susan has been the face of SmartTRAK Wound Care at industry meetings and has become a trusted advisor to many of our subscribers.

Gary will be representing SmartTRAK at SAWC Fall in Las Vegas, October 28-31. If you would like to meet with him to discuss the exciting new innovations ahead and learn how to network your entire organization with SmartTRAK, click the link below. To learn more about Gary, just keep reading!

Schedule a Meeting at SAWC Fall 2021!

Meet Gary Delhougne:

What is your role with SmartTRAK? As the General Manager of SmartTRAK’s Wound business, it is my role to lead the wound care team in delivering actionable business intelligence and decision-making tools to help our customers better serve patients and providers.

Topics: Wound Care
Continue Reading
2 min read

Picking Up Steam: Soft Tissue Fixation Market Recap

By Andy Knapik on 10/4/21 10:34 AM

Soft Tissue Fixation Continues to Pick Up Steam in Q2 2021

With the world trying to move past the negative impacts of COVID-19, the Soft Tissue Fixation market continued to make significant advancements in the second quarter of 2021. The quarter saw a continued rise in case volumes for elective sports medicine procedures worldwide driven primarily through market recovery in the wake of the COVID-19 pandemic. 

Among the many topics covered in detail in our comprehensive Q221 Soft Tissue Fixation Market Recap* are:

Continue Reading
2 min read

A Big Boost: Q221 US Infection Prevention-Vascular Access Adjunct Products Recap

By Susan Paquette on 9/30/21 9:30 AM

A big boost in Q2 with double-digit gains in all segments.

The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Among the many topics covered in detail in our comprehensive Q221 US Infection Prevention - Vascular Access Adjunct Products Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

SmartTRAK heads to Boston for NASS!

By Thomas Wallick on 9/23/21 9:00 AM

The SmartTRAK team is excited to head to Boston for the North American Spine Society (NASS) meeting. Need better business intelligence? Visit us at Booth 3719. SmartTRAK is the most comprehensive business intelligence platform for the MedTech industry. SmartTRAK's real-time data allows everyone in your organization to tap into the same data to drive strategic consistency and increase collaboration across your enterprise. Watch the video below to learn how SmartTRAK can help.


Planning to go to NASS? SmartTRAK will be represented in Boston by:

  • Julianne Burns, GM, Spine
  • Elise Wolf, VP & GM, Orthopedics
  • Kristina Meyer, CCO
  • Matt Golembeski, Dir. of Sales
  • Joe Mish, Dir. of Sales
  • Tim Patrick, Sr. Manager of Corporate Accounts

Meet with us in Boston to learn more about what's coming down the road, including:

  • Integration: Combine our data with yours and integrate it into your data analytic platform.
  • Customization: Tailor SmartTRAK to match your company's business and create your own business intelligence solution.
  • Expanded Functionality: Drive strategic consistency across your enterprise with user-specific enhancements and increase collaboration across your team

Schedule a meeting today!
We know you're going to love what's coming down the road!

Schedule a Meeting

Continue Reading
2 min read

Another Quarter of Healthy Growth: Q221 Trauma Market Recap

By Natasha Weeks on 9/22/21 4:00 PM

Trauma market rebounds as top segments drive growth amid easy YoY comps

The Trauma Market experienced another quarter of healthy growth as the WW and US Trauma Markets ended Q221 up YoY compared to Q220.  Looking forward to Q321, SmartTRAK feels that trauma procedures will likely not be as heavily impacted by the rise in the Delta variant as its elective procedure counterparts. We will continue to monitor the situation as the variant impacts states, as recently observed in Texas.

Among the many topics covered in detail in our comprehensive Q221 Trauma Market Recap* are:

Continue Reading
2 min read

SCS Boomerangs Back: Q221 Market Report

By Anne Staylor on 9/22/21 11:00 AM

A big boost in Q2 with double-digit gains in all segments.

The US and WW SCS Market boomeranged to pre-COVID levels in Q221 driven by declining COVID-19 cases and ongoing launches of new technologies and products. With easy comps against a quarter that was one of the hardest hit by the pandemic in 2020, Q221 growth was up in the double digits vs Q220 and was up in the low-single digits compared to Q219.

Among the many topics covered in detail in our comprehensive Q221 SCS Market Recap* are:

Continue Reading
3 min read

COVID's Silver Lining for Orthopedic Surgery: An Interview with Joseph Bosco lll, MD

By Lisa Mahan on 9/21/21 8:00 AM

At AAOS 2021, outgoing President Joseph Bosco III, MD, shares the positive changes in orthopedics accelerated by COVID-19 from the move of procedures to ASCs to increased use of technology

Joseph Bosco III, MD, vice-chair of clinical affairs for NYU Langone Orthopedics and outgoing president of the American Academy of Orthopedic Surgeons (AAOS) presided over the Academy during a transformative time accelerated by COVID-19. Dr. Bosco began his presidency in March 2020 just as the pandemic shut down many areas of the US impacting the healthcare system and orthopedic procedures. As Dr. Bosco prepared to turn over the reins at AAOS 2021, he spoke with SmartTRAK about his experience during the year and how the pandemic and technology are creating opportunities and accelerating trends that will change the practice of orthopedics for years to come.

To find out more, click on the following video. A link to download a complete transcript of the interview is also available below.

Download the "COVID's Silver Lining" interview transcript

SmartTRAK: Lisa Mahan here with Smart Track. Today, I have the honor to be talking to Dr. Joseph Bosco, III, outgoing president of the American Academy of Orthopedic Surgeons. Dr. Bosco, thank you for talking to me today.

Dr. Joseph Bosco: Well, thank you for having me.

Ending your term as president of AAOS must be a bit bittersweet. You've served during a challenging time with the disruption from COVID. How was it navigating through the pandemic?

Topics: Orthopedics
Continue Reading
2 min read

A Strong Recovery: Q221 Advanced Wound Care Market Recap

By Susan Paquette on 9/16/21 9:52 AM

Advanced Wound Care saw a strong recovery against a weak comparator.

For Q221, according to SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up, with all segments showing increases,

The US Wound Biologics market, comprising the vast majority of the global biologics market, includes the very competitive skin substitute or CTP (Cellular and/or Tissue-Based Products) market, the Topical Drug/Delivery category and Collagen Dressings. For Q221, the US market was up significantly, with CTPs accounting for the largest share, driven by Organogensis' substantial YoY gains. 

Among the many topics covered in detail in our comprehensive Q221 Advanced Wound Care Market Recap* are:

Topics: Wound Care
Continue Reading
3 min read

Studies Demonstrate Benefits of Custom 3D Metal Implants in Total Talus Replacement

By Nick Fitzpatrick on 9/14/21 2:26 PM

3D printing technologies continue to gain traction in total talus replacement, particularly as research demonstrates it’s an effective surgical option for patients with avascular necrosis. SmartTRAK highlights three recent studies illustrating how custom 3D printed metal implants are being used in total talus replacement surgery to restore normal joint anatomy and maintain joint range of motion.

SmartTRAK will be attending the 2021 American Orthopaedic Foot & Ankle Society Meeting in Charlotte, NC, Sept 22-25, to learn more about this technology and other advancements in foot & ankle treatment. Click for information on AOFAS and how to meet with us while in Charlotte to find out what SmartTRAK can do for you.


1) Three Dimension Printing Talar Prostheses for Total Replacement in Talar Necrosis and Collapse

    • SmartTRAK Analyst Summary:
      • A retrospective study evaluated anatomical talar replacement & clinical results of 9 patients w/ talar necrosis & collapse (TNC) using 3D printed metal talus implants and reported talar height increased 6.97mm & AOFAS hindfoot score improved 53.34mm at mean follow-up of 23.17 months. Int Orthop
    •  Conclusion:
      • The study concludes "The 3D printing patient-specific total talar prostheses allowed anatomical reconstruction in TNC. This novel treatment with 3D-printed prostheses could serve as a reliable patient-specific alternative in TNC.”

Topics: Orthopedics
Continue Reading
2 min read

SmartTRAK Hosts "The State of the Spine Market" Webinar

By Thomas Wallick on 9/13/21 9:49 AM

Register now for SmartTRAK's "The State of the Spine Market" webinar to be held on Wednesday, September 22, 2021 at 1:00 pm ET. Learn from SmartTRAK's General Manager of Spine, Julianne Burns, about the latest trends in the Spine market and how COVID-19 continues to impact the market. 

Agenda:
  • A Look Back: How COVID Impacted the Spine Market in Q1 & Q2
  • Q3 and Beyond: Dealing with Delta and More
  • Market Drivers & Trends
  • Q&A

Registration is free but limited. Sign up now to reserve your spot!

Julianne Burns, Smarttrak's General Manager, Spine, has 15+ years' experience in consulting, market development and marketing in the spine industry, including 7+ years at Medtronic Spinal & Biologics.

Continue Reading
3 min read

Know Before You Go: AOFAS 2021 in Charlotte, NC

By Thomas Wallick on 9/10/21 11:04 AM

After another difficult year, it's time to get out there and start reconnecting in person. SmartTRAK is excited to be traveling to Charlotte, NC to attend AOFAS at the Charlotte Convention Center, September 21-25.

SmartTRAK will be represented by Natasha Weeks, General Manager, Trauma & Extremities. Natasha is also managing our 3 newest modules, Pediatric Trauma, Pediatric Extremities and Pediatric Spine. If you would like to meet with Natasha while attending the meeting, just click here.

Now that we're back to in-person meetings, it's time to resume our continuing series Know Before You Go, so I sat down and asked Natasha a few questions about what she is looking forward to at AOFAS.

Continue Reading
3 min read

SmartTRAK's New Pediatric Modules: An Interview with the Analysts

By Thomas Wallick on 9/8/21 10:03 AM

We are excited to announce the addition of the full market view of Orthopedic Pediatrics (US) to the SmartTRAK platform, featuring 3 modules covering Pediatric Trauma, Pediatric Extremities and Pediatric Spine!

Natasha Weeks, General Manager, Trauma & Extremities, will be managing Pediatric Trauma & Extremities and the Spine module will be managed by Julianne Burns, General Manager, Spine.

In the following video, Lindsey Wolejko, SmartTRAK's Director of Marketing, discusses with Natasha and Julianne what's included in each new module and why we're so excited about these additions to the SmartTRAK platform. To request more information about these offerings, please click here.

Continue Reading
2 min read

Q221 Market Recap: US Surgical Matrices

By Doug Devens on 9/7/21 8:53 AM

Procedures using surgical matrices rebounded to normal levels again, with broad strength in both hernia and breast matrices.

Procedures using surgical matrices returned to approximately normal levels, though the Delta variant may make that recovery short-lived, as recently observed in Texas. The US Surgical Matrices market rebounded strongly in Q221 according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie* continued to lead the US Surgical Matrices market, with Becton Dickinson* (BD) bouncing back nearly as strongly.

Among the many topics covered in detail in our comprehensive Q221 US Surgical Matrices Market Recap* are:

Continue Reading
2 min read

Roaring Back: Q221 US Hemostats and Sealants Market Recap

By Doug Devens on 9/2/21 10:56 AM

The US market for Hemostats and Sealants came roaring back from its pandemic depths in Q221 as procedures returned to normal.  

As surgical procedures returned to approximately normal levels, the US Hemostats and Sealants market grew +51.1% YoY in Q221 according to SmartTRAK Financial Dashboard. Growth was strong across all segments and companies. However, the Delta variant may make that recovery short-lived, as recently observed in Texas.

Among the many topics covered in detail in our comprehensive Q221 US Hemostats and Sealants Market Recap* are:

Continue Reading
4 min read

An Interview with Medtronic's Brett Wall

By Anne Staylor on 8/30/21 10:04 AM

Brett Wall, EVP and President of Medtronic’s Neuroscience Portfolio, discusses changes and opportunities in the Neuroscience business in an interview with SmartTRAK. 

Brett Wall, EVP and President of Medtronic’s Neuroscience Portfolio, discusses how things are changing at Medtronic, his plans for the Neuroscience business and opportunities for growth in an interview with SmartTRAK. To find out more, including Wall’s vision for spine, neuromodulation and neurovascular, click on the following video. (25:58 min). A link to download a complete transcript of the interview is also provided below.

Continue Reading
2 min read

SmartTRAK Announces Innovations Ahead!

By Lindsey Wolejko on 8/27/21 9:18 AM

Easily accessible from your computer, tablet or smartphone, SmartTRAK is the most comprehensive business intelligence platform for the MedTech industry. SmartTRAK's real-time data allows everyone in your organization to tap into the same data to drive strategic consistency and increase collaboration across your enterprise. Need help with your roadmap? Watch the video below to learn how SmartTRAK can help.


Planning to go to AAOS? Meet with us in San Diego to learn more about what's coming down the road, including:

Continue Reading
2 min read

Q221 Total Joints Market Recap: Mixed Reviews

By Lisa Mahan on 8/26/21 9:15 AM

Q221 brought mixed reviews for Total Joints as Hips exceed pre-COVID levels and Knees fall flat

The Total Joints market accelerated sequentially with a return of patients and procedural volume growth in the quarter. However, compared to 2019, results varied by segment, The Hip Replacement segment put in the best performance with the US Hip Market in Q221 compared to pre-COVID’s Q219 levels. US Knees did not experience the same level of success as revenues were down.

Among the many topics covered in detail in our comprehensive Q221 Total Joints Market Recap* are:

  • Complete Q221 Total Joints Market Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • Total Joints News including Revenues, Data, Charts and Shares
  • US Market Growth Comparison Q221 vs Q219
  • Acquisitions, Deals & Financing News
  • New Products Hitting the Stage
  • Q221 Regulatory Highlights 
Topics: Orthopedics
Continue Reading
3 min read

Trends and Technologies in Stroke Care: An Interview with William Mack, MD

By Anne Staylor on 8/24/21 8:00 AM

SNIS President William J. Mack, MD discusses trends and technologies in stroke care in an interview with SmartTRAK

William J. Mack, MD, President of the Society of Neurointerventional Surgery (SNIS), provides insight into trends and technologies in stroke care in an interview with SmartTRAK at the SNIS 18 th  Annual Meeting in Colorado Springs held July 26-30, 2021. Key topics include: 
  • Advancing the stroke systems of care
  • Trends in practice and device use for acute ischemic stroke
  • Risks, benefits and challenges of treating more distal strokes
  • Promising technologies on the horizon, including robotics
  • Impact of COVID resurgence on clinical practice

To get the latest on stroke care, click on the following video to listen to a fascinating interview recorded live at SNIS (13:08). A link to download a transcript of the complete interview is also provided below.

Continue Reading
2 min read

Fueling the Race to Recovery: Q221 Extremities Market Recap

By Lisa Mahan on 8/23/21 9:30 AM

Declining COVID cases, M&A and new products fueled the race to recovery in the Extremities Market

As COVID cases declined in Q221 and patient confidence increased, the Extremities Market was off to the races with a rev-up in deal-making and new product launches. Elective procedure volumes started to make a comeback but were not pedal to the metal and still lagged pre-COVID levels. However, new product launches helped fuel growth in the quarter with the US Extremities Market +43.9% YoY, an increase of +8.2% compared to Q219, reflecting change over pre-COVID market conditions. 

Among the many topics covered in detail in our comprehensive Q221 Extremities Market Recap* are:

Topics: Orthopedics
Continue Reading
5 min read

Innovations in Wrist Arthroplasty: An Interview with Arnold-Peter Weiss, MD

By Lisa Mahan on 8/17/21 8:00 AM

Designing-Surgeon Dr. Arnold-Peter Weiss Discusses New WristMotion System Design, Outcomes and Implications

A new total wrist arthroplasty system, WristMotion*, is being introduced to the US market through Anika's*’ subsidiary, Arthrosurface*. WristMotion’s design is intended to address concerns of carpal loosening by incorporating a dual curvature design feature in the carpal side combined with a dorsal flange to allow for greater range of motion. In July, Anika announced* the first surgery utilizing the WristMotion Total Wrist Arthroplasty System was performed by designing-surgeon Arnold-Peter C. Weiss, MD, at University Orthopedics, RI.

To find out more, SmartTRAK interviewed Dr. Weiss about his early experience with the WristMotion total wrist and its implications for patients suffering from chronic wrist pain. To listen to the interview, recorded via Zoom, click on the following video (15:58 min). A link to download a transcript of the complete interview is also provided below.

Topics: Orthopedics
Continue Reading
3 min read

Studies Demonstrate Benefits of AR/VR in Total Joint Arthroplasty

By Nick Fitzpatrick on 8/16/21 9:53 AM

Computer-assisted technologies continue to gain traction in total joint arthroplasty, particularly as research demonstrates improved outcomes when clinicians employ surgical planning, simulation and navigation. SmartTRAK highlights three recent studies illustrating how augmented reality (AR) and virtual reality (VR) are being used in total knee replacement (TKR) surgery to improve accuracy in distal femoral resection, train nurses in complex knee revision arthroplasty procedures, and help surgeons lower long-term revision rates in TKR patients.

  • Augmented Reality-Assisted Femoral Bone Resection in Total Knee Arthroplasty

    • SmartTRAK Analyst Summary: A study of 10 resected femoral Sawbones specimens using an AR-based navigation system performed CT scans to measure the resection angle of the distal part of the femur and reported mean absolute value of the error in coronal alignment was significantly smaller in the AR-based navigation group than the intramedullary-guide group. JB JS Open Access. 2021 Jul 23

    • Conclusion: The study concludes “The AR-based navigation system may enable surgeons to perform distal femoral resection more accurately than with the conventional intramedullary guide during TKA.”
Continue Reading
10 min read

R&D Focus on Orthopedics: Patents, Products & Predictions

By Thomas Wallick on 8/9/21 3:46 PM

Despite the looming shadow of the emergence of the COVID-19 Delta variant, the worldwide MedTech industry continues to focus on the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma. We'll be at AAOS in San Diego, and if you would like to meet with us to see what SmartTRAK can do for you, just click here

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted in real time by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life  Sciences industry. 

Patents:

Globus*  

KB Medical was granted US Patent “Robotic navigation of robotic surgical systems” describing robotic surgical systems with built-in navigation capability & ability to update registration in real time & obviating the need for a separate navigation system. 11,071,594

Sutureless Repair of Soft Tissue

US Patent Application “Sutureless Repair of Soft Tissue” was published describing a sutureless method of repairing soft tissue defects in soft tissue including ligaments such as anterior cruciate ligaments (ACLs). 20210236130

Topics: Orthopedics
Continue Reading
4 min read

Neuromodulation Ramping Up in 2021

By Anne Staylor on 8/9/21 10:00 AM

As in-person meetings start to ramp up in 2021, SmartTRAK identifies the latest research, technologies and trends from ASPN and the mid-year NANS meetings

In this article, SmartTRAK identifies the latest research, technologies and trends at two recent neuromodulation meetings: the mid-year North American Neuromodulation Society (NANS) 2021 meeting, held July 15-18 in Orlando, FL and the American Society of Pain and Neuroscience (ASPN) meeting held in Miami, FL July 22-25. Following are the highlights of the neuromodulation news from these meetings in the areas of expanding indications, digital solutions and peripheral nerve stimulation (PNS) as covered by Anne Staylor, SmartTRAK's Executive Editor, VP & GM, Nuero Therapies.

To read this fascinating and informative article in it's entirety, you must be a subscriber to SmartTRAK...here's how to subscribe.

  • SCS for Painful Diabetic Neuropathy
    • In regards to expanded indications, the biggest news during the mid-year NANS meeting happened on Friday, July 16th when FDA approved Nevro’s* (NVRO) HF10 for ... 
  • Non-Surgical Refractory Back Pain.
    • During NVRO’s industry luncheon, Aaron Calodney, MD presented six-month data on 10 kHz SCS for non-surgical refractory back pain (NSRBP) vs CMM ...
  • Advances in Digital Solutions
    • All the major players in neuromodulation continue to advance patient care through innovative digital solutions and platforms designed to improve patient engagement and outcomes, track objective pain measures and ...
Continue Reading
1 min read

Moving the Ball Forward: Q121 CAS Spine Market Recap

By Elise Wolf on 8/2/21 10:24 AM

SmartTRAK reports that strong sales of spine robotic and enabling technology in Q121 continue to move the ball forward in the adoption curve. Companies are noting an inflection point on the pathway of these technologies becoming mainstream with centers buying multiple robots, and community and university hospitals adopting them.

Among the many topics covered in detail in our comprehensive Q121 CAS Spine Market Recap* are:

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles